<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35291879</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2046-2441</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Open biology</Title><ISOAbbreviation>Open Biol</ISOAbbreviation></Journal><ArticleTitle>Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review.</ArticleTitle><Pagination><StartPage>210289</StartPage><MedlinePgn>210289</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">210289</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsob.210289</ELocationID><Abstract><AbstractText>Developmental signalling pathways such as Wnt/&#x3b2;-catenin, Notch and Sonic hedgehog play a central role in nearly all the stages of neuronal development. The term 'embryonic' might appear to be a misnomer to several people because these pathways are functional during the early stages of embryonic development and adulthood, albeit to a certain degree. Therefore, any aberration in these pathways or their associated components may contribute towards a detrimental outcome in the form of neurological disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke. In the last decade, researchers have extensively studied these pathways to decipher disease-related interactions, which can be used as therapeutic targets to improve outcomes in patients with neurological abnormalities. However, a lot remains to be understood in this domain. Nevertheless, there is strong evidence supporting the fact that embryonic signalling is indeed a crucial mechanism as is manifested by its role in driving memory loss, motor impairments and many other processes after brain trauma. In this review, we explore the key roles of three embryonic pathways in modulating a range of homeostatic processes such as maintaining blood-brain barrier integrity, mitochondrial dynamics and neuroinflammation. In addition, we extensively investigated the effect of these pathways in driving the pathophysiology of a range of disorders such as Alzheimer's, Parkinson's and diabetic neuropathy. The concluding section of the review is dedicated to neurotherapeutics, wherein we identify and list a range of biological molecules and compounds that have shown enormous potential in improving prognosis in patients with these disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jha</LastName><ForeName>Niraj Kumar</ForeName><Initials>NK</Initials><Identifier Source="ORCID">0000-0001-9486-4069</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, Uttar Pradesh 201310, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-Chih</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, Uttar Pradesh 201310, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubey</LastName><ForeName>Rajni</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine Research, Taipei Medical University Hospital, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Lung-Wen</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Medicine Research, Taipei Medical University Hospital, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Information Technology Office, Taipei Medical University Hospital, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kar</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Indian Institute of Management Ahmedabad (IIMA), Gujarat 380015, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jha</LastName><ForeName>Saurabh Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, Uttar Pradesh 201310, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Piyush Kumar</ForeName><Initials>PK</Initials><Identifier Source="ORCID">0000-0002-3346-910X</Identifier><AffiliationInfo><Affiliation>Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, Uttar Pradesh 201310, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, Uttar Pradesh 201310, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gundamaraju</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ER Stress and Mucosal Immunology Laboratory, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pant</LastName><ForeName>Kumud</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Graphic Era deemed to be University Dehradun Uttarakhand, 248002 Dehradun, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mani</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector 62, Noida, Uttar Pradesh 201301, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sandeep Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Indian Scientific Education and Technology Foundation, Lucknow 226002, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maccioni</LastName><ForeName>Ricardo B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Laboratory of Neurosciences and Functional Medicine, International Center for Biomedicine (ICC) and Faculty of Sciences, University of Chile, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Tirtharaj</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, Uttar Pradesh 201310, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sachin Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Gaurav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, 302017 Jagatpura, Jaipur, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasher</LastName><ForeName>Parteek</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Petroleum and Energy Studies, Dehradun 248007, Uttarakhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dua</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales 2007, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Abhijit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata 700073, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Physics, School of Science, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Charu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, PO Box 15551, Al Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mughal</LastName><ForeName>Yasir Hayat</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Health Administration, College of Public Health and Health Informatics, Qassim University, Buraidah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruokolainen</LastName><ForeName>Janne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Applied Physics, School of Science, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kesari</LastName><ForeName>Kavindra Kumar</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Applied Physics, School of Science, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Espoo 00076, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojha</LastName><ForeName>Shreesh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7801-2966</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, PO Box 15551, Al Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Biol</MedlineTA><NlmUniqueID>101580419</NlmUniqueID><ISSNLinking>2046-2441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CNS</Keyword><Keyword MajorTopicYN="N">Notch</Keyword><Keyword MajorTopicYN="N">Sonic hedgehog</Keyword><Keyword MajorTopicYN="N">Wnt/&#x3b2;-catenin</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neurotherapeutics</Keyword></KeywordList><CoiStatement>We declare we have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35291879</ArticleId><ArticleId IdType="pmc">PMC8924757</ArticleId><ArticleId IdType="doi">10.1098/rsob.210289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soto C. 2003. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49-60. (10.1038/nrn1007)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1007</ArticleId><ArticleId IdType="pubmed">12511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, Orr H. 2006. The genetics of neurodegenerative diseases. J. Neurochem. 97, 1690-1699. (10.1111/j.1471-4159.2006.03979.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03979.x</ArticleId><ArticleId IdType="pubmed">16805777</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RC, Lockwood AH, Sonawane BR. 2005. Neurodegenerative diseases: an overview of environmental risk factors. Environ. Health Perspect. 113, 1250-1256. (10.1289/ehp.7567)</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.7567</ArticleId><ArticleId IdType="pmc">PMC1280411</ArticleId><ArticleId IdType="pubmed">16140637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueler H. 2009. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol. l218, 235-246. (10.1016/j.expneurol.2009.03.006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.03.006</ArticleId><ArticleId IdType="pubmed">19303005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieper N, Holmstrom KM, Ciceri D, Fiesel FC, Wolburg H. 2010. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. Exp. Cell Res. 316, 1213-1224. (10.1016/j.yexcr.2010.01.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2010.01.005</ArticleId><ArticleId IdType="pmc">PMC3063334</ArticleId><ArticleId IdType="pubmed">20064504</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Buylla A, Ihrie RA. 2014. Sonic hedgehog signaling in the postnatal brain. Semin. Cell Dev. Biol. 33, 1084-9521. (10.1016/j.semcdb.2014.05.008)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2014.05.008</ArticleId><ArticleId IdType="pmc">PMC4130786</ArticleId><ArticleId IdType="pubmed">24862855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesman S, von Oerthel L, Smidt MP. 2014. Mesodiencephalic dopaminergic neuronal differentiation does not involve GLI2A-mediated SHH-signaling and is under the direct influence of canonical WNT signaling. PLoS ONE 9, e97926. (10.1371/journal.pone.0097926)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097926</ArticleId><ArticleId IdType="pmc">PMC4035267</ArticleId><ArticleId IdType="pubmed">24865218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ables JL, Breunig JJ, Eisch AJ, Rakic P. 2011. Not(ch) just development: Notch signalling in the adult brain. Nat. Rev. Neurosci. 21, 269-283. (10.1038/nrn3024)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3024</ArticleId><ArticleId IdType="pmc">PMC3159580</ArticleId><ArticleId IdType="pubmed">21505516</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rster E, Bock HH, Herz J, Chai X, Frotscher M, Zhao S. 2010. Emerging topics in Reelin function. Eur. J. Neurosci. 31, 1511-1518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2942760</ArticleId><ArticleId IdType="pubmed">20525064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanski R, van Strien ME, van Tijn P, Hol EM. 2014. A star is born: new insights into the mechanism of astrogenesis. Cell Mol. Life Sci. 71, 433-447. (10.1007/s00018-013-1435-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1435-9</ArticleId><ArticleId IdType="pubmed">23907612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yin JC, Wesley CS. 2013. From Drosophila development to adult: clues to Notch function in long-term memory. Front. Cell. Neurosci. 7, 222. (10.3389/fncel.2013.00222)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00222</ArticleId><ArticleId IdType="pmc">PMC3836050</ArticleId><ArticleId IdType="pubmed">24312012</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquila G, Pannella M, Morelli MB, Caliceti C, Fortini C, Rizzo P, Ferrari R. 2013. The role of Notch pathway in cardiovascular diseases. Glob. Cardiol. Sci. Pract. 2013, 364-371. (10.5339/gcsp.2013.44)</Citation><ArticleIdList><ArticleId IdType="doi">10.5339/gcsp.2013.44</ArticleId><ArticleId IdType="pmc">PMC3991209</ArticleId><ArticleId IdType="pubmed">24749110</ArticleId></ArticleIdList></Reference><Reference><Citation>Chillakuri CR, Sheppard D, Lea SM, Handford PA. 2012. Notch receptor-ligand binding and activation: insights from molecular studies. Semin. Cell Dev. Biol. 23, 421-428. (10.1016/j.semcdb.2012.01.009)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2012.01.009</ArticleId><ArticleId IdType="pmc">PMC3415683</ArticleId><ArticleId IdType="pubmed">22326375</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwald I, Kovall R. 2013. 
Notch signaling: genetics and structure. WormBook. See
http://www.wormbook.org/chapters/www_lin12Notch.2/notchsignaling.pdf.</Citation></Reference><Reference><Citation>LaVoie MJ, Selkoe DJ. 2003. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments. J. Biol. Chem. 278, 34 427-34 437. (10.1074/jbc.M302659200)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M302659200</ArticleId><ArticleId IdType="pubmed">12826675</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta D, Batista M, Silva E, Trindade A, Henrique D, Duarte A, Lopes-da-Costa L. 2013. Dynamics of Notch pathway expression during mouse testis post-natal development and along the spermatogenic cycle. PLoS ONE 8, e72767. (10.1371/journal.pone.0072767)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0072767</ArticleId><ArticleId IdType="pmc">PMC3755970</ArticleId><ArticleId IdType="pubmed">24015274</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ, Wolfe MS. 2007. Presenilin: running with scissors in the membrane. Cell 131, 215-221. (10.1016/j.cell.2007.10.012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.012</ArticleId><ArticleId IdType="pubmed">17956719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao WX, Lin JH. 2012. Notch signaling pathway and human placenta. Int. J. Med. Sci. 9, 447-452. (10.7150/ijms.4593)</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.4593</ArticleId><ArticleId IdType="pmc">PMC3410364</ArticleId><ArticleId IdType="pubmed">22859905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ara&#xfa;jo GL, Ara&#xfa;jo JA, Schroeder T, Tort AB, Costa MR. 2014. Sonic hedgehog signaling regulates mode of cell division of early cerebral cortex progenitors and increases astrogliogenesis. Front. Cell. Neurosci. 8, 77. (10.3389/fncel.2014.00077)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00077</ArticleId><ArticleId IdType="pmc">PMC3949322</ArticleId><ArticleId IdType="pubmed">24653675</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackshaw S, Scholpp S, Placzek M, Ingraham H, Simerly R, Shimogori T. 2010. Molecular pathways controlling development of thalamus and hypothalamus: from neural specification to circuit formation. J. Neurosci. 30, 14 925-14 930. (10.1523/JNEUROSCI.4499-10.2010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4499-10.2010</ArticleId><ArticleId IdType="pmc">PMC6633850</ArticleId><ArticleId IdType="pubmed">21068293</ArticleId></ArticleIdList></Reference><Reference><Citation>Faigle R, Song H. 2013. Signaling mechanisms regulating adult neural stem cells and neurogenesis. Biochim. Biophys. Acta 1830, 2435-2448. (10.1016/j.bbagen.2012.09.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2012.09.002</ArticleId><ArticleId IdType="pmc">PMC3541438</ArticleId><ArticleId IdType="pubmed">22982587</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrova R, Garcia AD, Joyner AL. 2013. Titration of GLI3 repressor activity by sonic hedgehog signaling is critical for maintaining multiple adult neural stem cell and astrocyte functions. J. Neurosci. 33, 17 490-17 505. (10.1523/JNEUROSCI.2042-13.2013)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2042-13.2013</ArticleId><ArticleId IdType="pmc">PMC3812512</ArticleId><ArticleId IdType="pubmed">24174682</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinchisi G, Parada M, Lois P, Oyanadel C, Shaughnessy R, Gonzalez A, Palma V. 2013. Sonic Hedgehog modulates EGFR dependent proliferation of neural stem cells during late mouse embryogenesis through EGFR transactivation. Front. Cell. Neurosci. 7, 166. (10.3389/fncel.2013.00166)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00166</ArticleId><ArticleId IdType="pmc">PMC3783837</ArticleId><ArticleId IdType="pubmed">24133411</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant AA, Matsui W. 2010. Targeting hedgehog: a cancer stem cell pathway. Clin. Cancer Res. 16, 3130-3140. (10.1158/1078-0432.CCR-09-2846)</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-09-2846</ArticleId><ArticleId IdType="pmc">PMC2888641</ArticleId><ArticleId IdType="pubmed">20530699</ArticleId></ArticleIdList></Reference><Reference><Citation>Milla LA, Gonz&#xe1;lez-Ram&#xed;rez CN, Palma V. 2012. Sonic Hedgehog in cancer stem cells: a novel link with autophagy. Biol. Res. 45, 223-230. (10.4067/S0716-97602012000300004)</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/S0716-97602012000300004</ArticleId><ArticleId IdType="pubmed">23283432</ArticleId></ArticleIdList></Reference><Reference><Citation>Varjosalo M, Taipale J. 2008. Hedgehog: functions and mechanisms. Genes Dev. 22, 2454-2472. (10.1101/gad.1693608)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1693608</ArticleId><ArticleId IdType="pubmed">18794343</ArticleId></ArticleIdList></Reference><Reference><Citation>Daya-Grosjean L, Couv&#xe9;-Privat S. 2005. Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett. 225, 181-192. (10.1016/j.canlet.2004.10.003)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2004.10.003</ArticleId><ArticleId IdType="pubmed">15978322</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufer E, Kesper D, Vortkamp A, King P. 2012. Sonic hedgehog signaling during adrenal development. Mol. Cell Endocrinol. 351, 19-27. (10.1016/j.mce.2011.10.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2011.10.002</ArticleId><ArticleId IdType="pmc">PMC3288303</ArticleId><ArticleId IdType="pubmed">22020162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin LL, de Sauvage FJ. 2006. Targeting the Hedgehog pathway in cancer. Nat. Rev. Drug Discov. 5, 1026-1033. (10.1038/nrd2086)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2086</ArticleId><ArticleId IdType="pubmed">17139287</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Bent ML, Sterken MG, Volkers RJ, Riksen JA, Schmid T, Hajnal A, Kammenga JE, Snoek LB. 2014. Loss-of-function of &#x3b2;-catenin bar-1 slows development and activates the Wnt pathway in Caenorhabditis elegans. Sci. Rep. 4, 4926. (10.1038/srep04926)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep04926</ArticleId><ArticleId IdType="pmc">PMC4019968</ArticleId><ArticleId IdType="pubmed">24819947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan KA, Cheyette BN. 2012. Wnt signaling in vertebrate neural development and function. J. Neuroimmune Pharmacol. 7, 774-787. (10.1007/s11481-012-9404-x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-012-9404-x</ArticleId><ArticleId IdType="pmc">PMC3518582</ArticleId><ArticleId IdType="pubmed">23015196</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DC, Harvey K. 2014. The regulation and deregulation of Wnt signaling by PARK genes in health and disease. J. Mol. Cell Biol. l6, 3-12. (10.1093/jmcb/mjt037)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjt037</ArticleId><ArticleId IdType="pmc">PMC4344548</ArticleId><ArticleId IdType="pubmed">24115276</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez VA, Sabatini BL. 2007. Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci. 30, 79-97. (10.1146/annurev.neuro.30.051606.094222)</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.30.051606.094222</ArticleId><ArticleId IdType="pubmed">17280523</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogolla N, Galimberti I, Caroni P. 2007. Structural plasticity of axon terminals in the adult. Curr. Opin. Neurobiol. 17, 516-524. (10.1016/j.conb.2007.09.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2007.09.002</ArticleId><ArticleId IdType="pubmed">17950593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Matamoros A, Salcedo-Tello P, Avila-Mu&#xf1;oz E, Zepeda A, Arias C. 2013. Role of wnt signaling in the control of adult hippocampal functioning in health and disease: therapeutic implications. Curr. Neuropharmacol. 11, 465-476. (10.2174/1570159X11311050001)</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X11311050001</ArticleId><ArticleId IdType="pmc">PMC3763754</ArticleId><ArticleId IdType="pubmed">24403870</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JR. 2002. The Wnts. Genome Biol. 3, 3001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC150458</ArticleId><ArticleId IdType="pubmed">11806834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cos&#xed;n-Roger J, Ortiz-Masi&#xe1; D, Calatayud S, Hern&#xe1;ndez C, Alvarez A, Hinojosa J, Esplugues JV, Barrachina MD. 2013. M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis. PLoS ONE 8, e78128. (10.1371/journal.pone.0078128)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0078128</ArticleId><ArticleId IdType="pmc">PMC3805515</ArticleId><ArticleId IdType="pubmed">24167598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei G, Zou Z, Fu S, Xia L, Zhou J, Zhang Y, Tuo Y, Wang Z, Jin D. 2014. Substance P activates the Wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells. Int. J. Mol. Sci. 15, 6224-6240. (10.3390/ijms15046224)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15046224</ArticleId><ArticleId IdType="pmc">PMC4013624</ArticleId><ArticleId IdType="pubmed">24733069</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi K, Shafer B, Lo C, Tissir F, Goffinet AM, Zou Y. 2013. Antagonistic functions of Dishevelleds regulate Frizzled3 endocytosis via filopodia tips in Wnt-mediated growth cone guidance. J. Neurosci. 33, 19 071-19 085. (10.1523/JNEUROSCI.2800-13.2013)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2800-13.2013</ArticleId><ArticleId IdType="pmc">PMC3850035</ArticleId><ArticleId IdType="pubmed">24305805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Sun W, Ma J, Pan Y, Wang L, Zhang W. 2014. Polycystin-1 mediates mechanical strain-induced osteoblastic mechanoresponses via potentiation of intracellular calcium and Akt/&#x3b2;-catenin pathway. PLoS ONE 9, e91730. (10.1371/journal.pone.0091730)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091730</ArticleId><ArticleId IdType="pmc">PMC3950298</ArticleId><ArticleId IdType="pubmed">24618832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop NA, Lu T, Yankner BA. 2010. Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535. (10.1038/nature08983)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08983</ArticleId><ArticleId IdType="pmc">PMC2927852</ArticleId><ArticleId IdType="pubmed">20336135</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzo A, et al. 2016. Reversal of synapse degeneration by restoring Wnt signalling in the adult hippocampus. Curr. Biol. 26, 2551-2561. (10.1016/j.cub.2016.07.024)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2016.07.024</ArticleId><ArticleId IdType="pmc">PMC5070786</ArticleId><ArticleId IdType="pubmed">27593374</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod F, et al. 2018. Wnt signaling mediates LTP-dependent spine plasticity and AMPAR localization through frizzled-7 receptors. Cell Rep. 23, 1060-1071. (10.1016/j.celrep.2018.03.119)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.119</ArticleId><ArticleId IdType="pmc">PMC5946458</ArticleId><ArticleId IdType="pubmed">29694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Folke J, Pakkenberg B, Brudek T. 2018. Impaired Wnt signaling in the prefrontal cortex of Alzheimer's disease. Mol. Neurobiol. 56, 873-891. (10.1007/s12035-018-1103-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1103-z</ArticleId><ArticleId IdType="pubmed">29804228</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Tapia-Rojas C, Lindsay CB, Zolezzi JM. 2020. Wnt signaling pathway dysregulation in the aging brain: lessons from the Octodon degus. Front. Cell Dev. Biol. 8, 734. (10.3389/fcell.2020.00734)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00734</ArticleId><ArticleId IdType="pmc">PMC7419590</ArticleId><ArticleId IdType="pubmed">32850846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor A, Nation DA. 2021. Role of Notch signaling in neurovascular aging and Alzheimer's disease. In Seminars in cell &amp; developmental biology, vol. 116, pp. 90-97. Academic Press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236496</ArticleId><ArticleId IdType="pubmed">33384205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao PJ, Petralia RS, Mattson MP. 2016. Sonic hedgehog signaling and hippocampal neuroplasticity. Trends Neurosci. 39, 840-850. (10.1016/j.tins.2016.10.001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2016.10.001</ArticleId><ArticleId IdType="pmc">PMC5148655</ArticleId><ArticleId IdType="pubmed">27865563</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK. 2019. Nuclear factor-kappa &#x3b2; as a therapeutic target for Alzheimer's disease. J. Neurochem. 150, 113-137. (10.1111/jnc.14687)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14687</ArticleId><ArticleId IdType="pubmed">30802950</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Zhao B, Deng Y, Shangguan S, Zhou F, Zhou W, Li X, Li Y, Chen G. 2016. Notch signaling in cerebrovascular diseases (review). Mol. Med. Rep. 14, 2883-2898. (10.3892/mmr.2016.5641)</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.5641</ArticleId><ArticleId IdType="pmc">PMC5042775</ArticleId><ArticleId IdType="pubmed">27574001</ArticleId></ArticleIdList></Reference><Reference><Citation>Troletti CD, et al. 2018. Notch signaling is impaired during inflammation in a lunatic Fringe-dependent manner. Brain Behav. Immun. 69, 48-56. (10.1016/j.bbi.2017.12.016)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.12.016</ArticleId><ArticleId IdType="pubmed">29289661</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Pan L, Moens CB, Appel B. 2014. Notch3 establishes brain vascular integrity by regulating pericyte number. Development 141, 307-317. (10.1242/dev.096107)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.096107</ArticleId><ArticleId IdType="pmc">PMC3879812</ArticleId><ArticleId IdType="pubmed">24306108</ArticleId></ArticleIdList></Reference><Reference><Citation>Henshall TL, et al. 2015. Notch3 is necessary for blood vessel integrity in the central nervous system. Arterioscler. Thromb. Vasc. Biol. 35, 409-420. (10.1161/ATVBAHA.114.304849)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.114.304849</ArticleId><ArticleId IdType="pubmed">25477343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R, Cai J, Kenyon L, Iozzo R, Rosenwasser R, Iacovitti L. 2019. Systemic factors trigger vasculature cells to drive Notch signaling and neurogenesis in neural stem cells in the adult brain. Stem Cells 37, 395-406. (10.1002/stem.2947)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2947</ArticleId><ArticleId IdType="pmc">PMC7028145</ArticleId><ArticleId IdType="pubmed">30431198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Nathans J. 2014. Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev. Cell 31, 248-256. (10.1016/j.devcel.2014.08.018)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2014.08.018</ArticleId><ArticleId IdType="pmc">PMC4223636</ArticleId><ArticleId IdType="pubmed">25373781</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bner K, et al. 2018. Wnt/&#x3b2;-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling. Nat. Commun. 9, 4860. (10.1038/s41467-018-07302-x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07302-x</ArticleId><ArticleId IdType="pmc">PMC6242933</ArticleId><ArticleId IdType="pubmed">30451830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran KA, Zhang X, Predescu D, Huang X, Machado RF, G&#xf6;thert JR, Malik AB, Valyi-Nagy T, Zhao YY. 2016. Endothelial &#x3b2;-catenin signaling is required for maintaining adult blood-brain barrier integrity and central nervous system homeostasis. Circulation 133, 177-186. (10.1161/CIRCULATIONAHA.115.015982)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.015982</ArticleId><ArticleId IdType="pmc">PMC4814374</ArticleId><ArticleId IdType="pubmed">26538583</ArticleId></ArticleIdList></Reference><Reference><Citation>Artus C, Glacial F, Ganeshamoorthy K, Ziegler N, Godet M, Guilbert T, Liebner S, Couraud PO. 2014. The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells. J. Cereb. Blood Flow Metab. 34, 433-440. (10.1038/jcbfm.2013.213)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2013.213</ArticleId><ArticleId IdType="pmc">PMC3948118</ArticleId><ArticleId IdType="pubmed">24346691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. 2014. Interleukin-1&#x3b2; induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. PLoS ONE 9, e110024. (10.1371/journal.pone.0110024)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110024</ArticleId><ArticleId IdType="pmc">PMC4196962</ArticleId><ArticleId IdType="pubmed">25313834</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez JI, et al. 2011. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334, 1727-1731. (10.1126/science.1206936)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1206936</ArticleId><ArticleId IdType="pubmed">22144466</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia YP, et al. 2013. Recombinant human sonic hedgehog protein regulates the expression of ZO-1 and occludin by activating angiopoietin-1 in stroke damage. PLoS ONE 8, e68891. (10.1371/journal.pone.0068891)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068891</ArticleId><ArticleId IdType="pmc">PMC3720889</ArticleId><ArticleId IdType="pubmed">23894369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugbode CI, Smith I, Whalley BJ, Hirst WD, Rattray M. 2017. Sonic Hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection. J. Neurochem. 142, 429-443. (10.1111/jnc.14064)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14064</ArticleId><ArticleId IdType="pmc">PMC5575469</ArticleId><ArticleId IdType="pubmed">28485896</ArticleId></ArticleIdList></Reference><Reference><Citation>Han YG, Spassky N, Romaguera-Ros M, Garcia-Verdugo JM, Aguilar A, Schneider-Maunoury S, Alvarez-Buylla A. 2008. Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells. Nat. Neurosci. 11, 277-284. (10.1038/nn2059)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2059</ArticleId><ArticleId IdType="pubmed">18297065</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma V, et al. 2005. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 132, 335-344. (10.1242/dev.01567)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01567</ArticleId><ArticleId IdType="pmc">PMC1431583</ArticleId><ArticleId IdType="pubmed">15604099</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvadurai HJ, Mason JO. 2012. Activation of Wnt/&#x3b2;-catenin signalling affects differentiation of cells arising from the cerebellar ventricular zone. PLoS ONE 7, e42572. (10.1371/journal.pone.0042572)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042572</ArticleId><ArticleId IdType="pmc">PMC3411831</ArticleId><ArticleId IdType="pubmed">22880037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lie DC, et al. 2005. Wnt signaling regulates adult hippocampal neurogenesis. Nature 473, 1370-1375. (10.1038/nature04108)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04108</ArticleId><ArticleId IdType="pubmed">16251967</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti B. 2018. Wnt/&#x3b2;-catenin signaling pathway governs a full program for dopaminergic neuron survival, neurorescue and regeneration in the MPTP mouse model of Parkinson's disease. Int. J. Mol. Sci. 19, 3743. (10.3390/ijms19123743)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123743</ArticleId><ArticleId IdType="pmc">PMC6321180</ArticleId><ArticleId IdType="pubmed">30477246</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H, Stevens CF, Gage FH. 2002. Astroglia induce neurogenesis from adult neural stem cells. Nature 417, 39-44. (10.1038/417039a)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/417039a</ArticleId><ArticleId IdType="pubmed">11986659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim DA, Alvarez-Buylla A. 1999. Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. Proc. Natl Acad. Sci. USA 96, 7526-7531. (10.1073/pnas.96.13.7526)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.13.7526</ArticleId><ArticleId IdType="pmc">PMC22119</ArticleId><ArticleId IdType="pubmed">10377448</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelo-Branco G, Rawal N, Arenas E. 2004. GSK-3&#x3b2; inhibition/&#x3b2;-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J. Cell Sci. 117, 5731-5737. (10.1242/jcs.01505)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01505</ArticleId><ArticleId IdType="pubmed">15522889</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelo-Branco G, Sousa KM, Bryja V, Pinto L, Wagner J, Arenas E. 2006. Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol. Cell Neurosci. 31, 251-262. (10.1016/j.mcn.2005.09.014)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.09.014</ArticleId><ArticleId IdType="pubmed">16243537</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, Cao Q, Wu C, Kaur C, Hao A, Ling EA. 2013. Notch signaling in the central nervous system with special reference to its expression in microglia. CNS Neurol. Disord. Drug Targets 12, 807-814. (10.2174/18715273113126660172)</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/18715273113126660172</ArticleId><ArticleId IdType="pubmed">24047525</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi H, Hu J, Qian J, Hackam AS. 2012. Expression of brain-derived neurotrophic factor is regulated by the Wnt signaling pathway. Neuroreport 23, 189-194. (10.1097/WNR.0b013e32834fab06)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0b013e32834fab06</ArticleId><ArticleId IdType="pmc">PMC3265333</ArticleId><ArticleId IdType="pubmed">22198686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Shi Y, Peng Y, Zhong L, Zhu S, Zhang W, Tang SJ. 2018. Neuron activity-induced Wnt signaling up-regulates expression of brain-derived neurotrophic factor in the pain neural circuit. J. Biol. Chem. 293, 15 641-15 651. (10.1074/jbc.RA118.002840)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.002840</ArticleId><ArticleId IdType="pmc">PMC6177598</ArticleId><ArticleId IdType="pubmed">30139740</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JW, Ru J, Ma W, Gao Y, Liang Z, Liu J, Guo JH, Li LY. 2015. BDNF promotes the growth of human neurons through crosstalk with the Wnt/&#x3b2;-catenin signaling pathway via GSK-3&#x3b2;. Neuropeptides 54, 35-46. (10.1016/j.npep.2015.08.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npep.2015.08.005</ArticleId><ArticleId IdType="pubmed">26311646</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, et al. 2016. The relationship between BDNF and the Wnt signaling pathway in the growth of human neural stem cell (P5.148). Neurology 86 (16 Supplement), P5.148.</Citation></Reference><Reference><Citation>Liu S, Yao JL, Wan XX, Song ZJ, Miao S, Zhao Y, Wang XL, Liu YP. 2018. Sonic hedgehog signaling in spinal cord contributes to morphine-induced hyperalgesia and tolerance through upregulating brain-derived neurotrophic factor expression. J. Pain Res. 11, 649-659. (10.2147/JPR.S153544)</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S153544</ArticleId><ArticleId IdType="pmc">PMC5892616</ArticleId><ArticleId IdType="pubmed">29662325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond CW, Angeloni N, Harrington D, Stupp S, Podlasek CA. 2013. Sonic Hedgehog regulates brain-derived neurotrophic factor in normal and regenerating cavernous nerves. J. Sex Med. 10, 730-737. (10.1111/jsm.12030)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsm.12030</ArticleId><ArticleId IdType="pmc">PMC3593960</ArticleId><ArticleId IdType="pubmed">23237228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Partin J. 1999. Evidence for mitochondrial control of neuronal polarity. J. Neurosci. Res. 56, 8-20. (10.1002/(SICI)1097-4547(19990401)56:1&lt;8::AID-JNR2&gt;3.0.CO;2-G)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19990401)56:1&lt;8::AID-JNR2&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">10213470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruthel G, Hollenbeck PJ. 2003. Response of mitochondrial traffic to axon determination and differential branch growth. J. Neurosci. 23, 8618-8624. (10.1523/JNEUROSCI.23-24-08618.2003)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-24-08618.2003</ArticleId><ArticleId IdType="pmc">PMC6740379</ArticleId><ArticleId IdType="pubmed">13679431</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Okamoto K, Hayashi Y, Sheng M. 2004. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887. (10.1016/j.cell.2004.11.003)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.11.003</ArticleId><ArticleId IdType="pubmed">15607982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao PJ, Petralia RS, Ott C, Wang Y, Lippincott-Schwartz J, Mattson MP. 2015. Dendrosomatic sonic Hedgehog signaling in hippocampal neurons regulates axon elongation. J. Neurosci. 35, 16 126-16 141. (10.1523/JNEUROSCI.1360-15.2015)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1360-15.2015</ArticleId><ArticleId IdType="pmc">PMC4682780</ArticleId><ArticleId IdType="pubmed">26658865</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao PJ, et al. 2017. Sonic hedgehog pathway activation increases mitochondrial abundance and activity in hippocampal neurons. Mol. Biol. Cell 28, 387-395. (10.1091/mbc.e16-07-0553)</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e16-07-0553</ArticleId><ArticleId IdType="pmc">PMC5341723</ArticleId><ArticleId IdType="pubmed">27932496</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Liu Y, Tian X. 2018. Rosuvastatin improves neurite outgrowth of cortical neurons against oxygen-glucose deprivation via Notch1-mediated mitochondrial biogenesis and functional improvement. Front. Cell. Neurosci. 12, 6. (10.3389/fncel.2018.00006)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00006</ArticleId><ArticleId IdType="pmc">PMC5776084</ArticleId><ArticleId IdType="pubmed">29387001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen FZ, Zhao Y, Chen HZ. 2019. MicroRNA-98 reduces amyloid &#x3b2;-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer's disease mice. Int. J. Mol. Med. 43, 91-102. (10.3892/ijmm.2018.3957)</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2018.3957</ArticleId><ArticleId IdType="pmc">PMC6257854</ArticleId><ArticleId IdType="pubmed">30365070</ArticleId></ArticleIdList></Reference><Reference><Citation>Arr&#xe1;zola MS, Silva-Alvarez C, Inestrosa NC. 2015. How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario. Front. Cell. Neurosci. 9, 166. (10.3389/fncel.2015.00166)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00166</ArticleId><ArticleId IdType="pmc">PMC4419851</ArticleId><ArticleId IdType="pubmed">25999816</ArticleId></ArticleIdList></Reference><Reference><Citation>Arr&#xe1;zola MS, Ramos-Fern&#xe1;ndez E, Cisternas P, Ordenes D, Inestrosa NC. 2017. Wnt signaling prevents the A&#x3b2; oligomer-induced mitochondrial permeability transition pore opening preserving mitochondrial structure in hippocampal neurons. PLoS ONE 12, e0168840. (10.1371/journal.pone.0168840)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168840</ArticleId><ArticleId IdType="pmc">PMC5218554</ArticleId><ArticleId IdType="pubmed">28060833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma B, Hottiger MO. 2016. Crosstalk between Wnt/&#x3b2;-catenin and NF-&#x3ba;B signaling pathway during inflammation. Front. Immunol. 7, 378. (10.3389/fimmu.2016.00378)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00378</ArticleId><ArticleId IdType="pmc">PMC5031610</ArticleId><ArticleId IdType="pubmed">27713747</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti B, Pluchino S. 2013. Wnt your brain be inflamed? Yes, it Wnt! Trends Mol. Med. 19, 144-156. (10.1016/j.molmed.2012.12.001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2012.12.001</ArticleId><ArticleId IdType="pmc">PMC3595301</ArticleId><ArticleId IdType="pubmed">23312954</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Chi S, Xue J, Yang J, Li F, Liu X. 2016. Emerging role and therapeutic implication of Wnt signaling pathways in autoimmune diseases. J. Immunol. Res. 2016, 9392132. (10.1155/2016/9392132)</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9392132</ArticleId><ArticleId IdType="pmc">PMC4826689</ArticleId><ArticleId IdType="pubmed">27110577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma B, Fey M, Hottiger MO. 2015. WNT/&#x3b2;-catenin signaling inhibits CBP-mediated RelA acetylation and expression of proinflammatory NF-&#x3ba;B target genes. J. Cell Sci. 128, 2430-2436. (10.1242/jcs.168542)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.168542</ArticleId><ArticleId IdType="pubmed">26021349</ArticleId></ArticleIdList></Reference><Reference><Citation>Oderup C, LaJevic M, Butcher EC. 2013. Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance. J. Immunol. 190, 6126-6134. (10.4049/jimmunol.1203002)</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203002</ArticleId><ArticleId IdType="pmc">PMC3698971</ArticleId><ArticleId IdType="pubmed">23677472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li M, Liu N, Liu P, Qiao J. 2015. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3 K/AKT/NF-&#x3ba;B signaling in the granulosa cells of PCOS patients. J. Clin. Endocrinol. Metab. 100, 201-211. (10.1210/jc.2014-2419)</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2014-2419</ArticleId><ArticleId IdType="pubmed">25303486</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Zhong L, Yang X, Andersson T, Huang M, Tang SJ. 2011. WNT5A signaling contributes to A&#x3b2;-induced neuroinflammation and neurotoxicity. PLoS ONE 6, e22920. (10.1371/journal.pone.0022920)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022920</ArticleId><ArticleId IdType="pmc">PMC3157339</ArticleId><ArticleId IdType="pubmed">21857966</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Chang J, Liu Y, Li J, Kevork K, Al-Hezaimi K, Graves DT, Park N-H, Wang C-Y. 2014. Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-&#x3ba;B. Nat. Med. 20, 1009-1017. (10.1038/nm.3586)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3586</ArticleId><ArticleId IdType="pmc">PMC4159424</ArticleId><ArticleId IdType="pubmed">25108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Halleskog C, et al. 2011. WNT signaling in activated microglia is proinflammatory. Glia 59, 119-131. (10.1002/glia.21081)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21081</ArticleId><ArticleId IdType="pmc">PMC3064522</ArticleId><ArticleId IdType="pubmed">20967887</ArticleId></ArticleIdList></Reference><Reference><Citation>Halleskog C, Schulte G. 2013. WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microglia. J. Neurochem. 125, 803-808. (10.1111/jnc.12250)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12250</ArticleId><ArticleId IdType="pubmed">23534675</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi H, Patel AK, Sodhi CP, Hackam DJ, Hackam AS. 2012. Novel role for the innate immune receptor toll-like receptor 4 (TLR4) in the regulation of the Wnt signaling pathway and photoreceptor apoptosis. PLoS ONE 7, e36560. (10.1371/journal.pone.0036560)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036560</ArticleId><ArticleId IdType="pmc">PMC3355158</ArticleId><ArticleId IdType="pubmed">22615780</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinath J, Holla S, Mahadik K, Prakhar P, Singh V, Balaji KN. 2014. The WNT signaling pathway contributes to dectin-1-dependent inhibition of toll-like receptor-induced inflammatory signature. Mol. Cell. Biol. 34, 4301-4314. (10.1128/MCB.00641-14)</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00641-14</ArticleId><ArticleId IdType="pmc">PMC4248746</ArticleId><ArticleId IdType="pubmed">25246634</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M, Rehani K, Jope RS, Michalek SM. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784. (10.1038/ni1221)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1221</ArticleId><ArticleId IdType="pmc">PMC1933525</ArticleId><ArticleId IdType="pubmed">16007092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhang X, Dong H, Zhang S, Sun J, Qian Y. 2016. Lithium ameliorates LPS-induced astrocytes activation partly via inhibition of Toll-like receptor 4 expression. Cell Physiol. Biochem. 38, 714-725. (10.1159/000443028)</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443028</ArticleId><ArticleId IdType="pubmed">26870942</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Li H, Yin Y, Zhang Y, Liu Z, Liu H. 2017. Interactions of Notch1 and TLR4 signaling pathways in DRG neurons of in vivo and in vitro models of diabetic neuropathy. Sci. Rep. 7, 14923. (10.1038/s41598-017-15053-w)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15053-w</ArticleId><ArticleId IdType="pmc">PMC5668305</ArticleId><ArticleId IdType="pubmed">29097792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui XY, et al. 2004. NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J. Biol. Chem. 279, 25 858-25 865. (10.1074/jbc.M313505200)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M313505200</ArticleId><ArticleId IdType="pubmed">15082708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutolf S, Radtke F, Aguet M, Suter U, Taylor V. 2002. Notch1 is required for neuronal and glial differentiation in the cerebellum. Development 129, 373-385. (10.1242/dev.129.2.373)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.129.2.373</ArticleId><ArticleId IdType="pubmed">11807030</ArticleId></ArticleIdList></Reference><Reference><Citation>Stump G, Durrer A, Klein AL, Lutolf S, Suter U, Taylor V. 2002. Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain. Mech. Dev. 114, 153-159. (10.1016/S0925-4773(02)00043-6)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4773(02)00043-6</ArticleId><ArticleId IdType="pubmed">12175503</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanigaki K, Nogaki F, Takahashi J, Tashiro K, Kurooka H, Honjo T. 2001. Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate. Neuron 29, 45-55. (10.1016/S0896-6273(01)00179-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00179-9</ArticleId><ArticleId IdType="pubmed">11182080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W, Jiang MM, Weinmaster G, Jan LY, Jan YN. 1997. Differential expression of mammalian Numb, Numblike and Notch1 suggests distinct roles during mouse cortical neurogenesis. Development 124, 1887-1897. (10.1242/dev.124.10.1887)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.124.10.1887</ArticleId><ArticleId IdType="pubmed">9169836</ArticleId></ArticleIdList></Reference><Reference><Citation>Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K. 2008. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat. Med. 14, 290-298. (10.1038/nm1731)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1731</ArticleId><ArticleId IdType="pubmed">18311147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao PN, Wei SC, Huang MT, Lee MC, Chou HC, Chen C-Y, Hsieh W-S. 2011. Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response. J. Biomed. Sci. 18, 56. (10.1186/1423-0127-18-56)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-18-56</ArticleId><ArticleId IdType="pmc">PMC3176188</ArticleId><ArticleId IdType="pubmed">21843347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongchana W, Palaga T. 2012. Direct regulation of interleukin-6 expression by Notch signaling in macrophages. Cell Mol. Immunol. 9, 155-162. (10.1038/cmi.2011.36)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2011.36</ArticleId><ArticleId IdType="pmc">PMC4002803</ArticleId><ArticleId IdType="pubmed">21983868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Wang C, Liu Z, Liu X, Han C, Cao X, Li N. 2012. Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor kappaB activation. J. Biol. Chem. 287, 6208-6217. (10.1074/jbc.M111.310375)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.310375</ArticleId><ArticleId IdType="pmc">PMC3307302</ArticleId><ArticleId IdType="pubmed">22205705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Lu J, Kaur C, Sivakumar V, Li F, Cheah PS, Dheen ST, Ling E-A. 2008. Expression of Notch-1 receptor and its ligands Jagged-1 and Delta-1 in amoeboid microglia in postnatal rat brain and murine BV-2 cells. Glia 56, 1224-1237. (10.1002/glia.20692)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20692</ArticleId><ArticleId IdType="pubmed">18449946</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandbarbe L, Michelucci A, Heurtaux T, Hemmer K, Morga E, Heuschling P. 2007. Notch signaling modulates the activation of microglial cells. Glia 55, 1519-1530. (10.1002/glia.20553)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20553</ArticleId><ArticleId IdType="pubmed">17705199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Z, Chigurupati S, Arumugam TV, Jo DG, Li H, Chan SL. 2011. Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia. Stroke 42, 2589-2594. (10.1161/STROKEAHA.111.614834)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.614834</ArticleId><ArticleId IdType="pubmed">21737799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, Kan EM, Kaur C, Dheen ST, Hao A, Lu J, Ling EA. 2013. Notch-1 signaling regulates microglia activation via NF-&#x3ba;B pathway after hypoxic exposure in vivo and in vitro. PLoS ONE 8, e78439. (10.1371/journal.pone.0078439)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0078439</ArticleId><ArticleId IdType="pmc">PMC3819391</ArticleId><ArticleId IdType="pubmed">24223152</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele L, Babrilovich DI. 2001. Notch-1 regulates NF-jB activity in hemopoietic progenitor cells. J. Immunol. 167, 4458-4467. (10.4049/jimmunol.167.8.4458)</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.167.8.4458</ArticleId><ArticleId IdType="pubmed">11591772</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez L, et al. 2008. Tumor necrosis factor-a and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp. Hematol. 36, 545-558. (10.1016/j.exphem.2007.12.012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2007.12.012</ArticleId><ArticleId IdType="pmc">PMC3437760</ArticleId><ArticleId IdType="pubmed">18439488</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaga T, Buranaruk C, Rengpipat S, Fauq AH, Golde TE, Kaufmann SH, Osborne BA. 2008. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur. J. Immunol. 38, 174-183. (10.1002/eji.200636999)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200636999</ArticleId><ArticleId IdType="pubmed">18085664</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, Golde TE, Sonenshein GE, Osborne BA. 2006. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J. 25, 129-138. (10.1038/sj.emboj.7600902)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600902</ArticleId><ArticleId IdType="pmc">PMC1356346</ArticleId><ArticleId IdType="pubmed">16319921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang HL, Tergaonkar V. 2007. Notch and NF-jB signaling pathways: do they collaborate in normal vertebrate brain development and function? Bioessays 29, 1039-1047. (10.1002/bies.20647)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20647</ArticleId><ArticleId IdType="pubmed">17876798</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha NK, Kar R, Niranjan R. 2019. ABC transporters in neurological disorders: an important gateway for botanical compounds mediated neuro-therapeutics. Rev. Curr. Top. Med. Chem. 19, 795-811. (10.2174/1568026619666190412121811)</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026619666190412121811</ArticleId><ArticleId IdType="pubmed">30977450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman SE, El Khoury J. 2013. The neuroimmune system in Alzheimer's disease: the glass is half full. J. Alzheimers Dis. 33(Suppl.1), S295-S302. (10.3233/JAD-2012-129027)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-129027</ArticleId><ArticleId IdType="pmc">PMC8176079</ArticleId><ArticleId IdType="pubmed">22751176</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade V, Cortes N, Guzman-Martinez L, Maccioni R. 2017. An overview of the links between behavioral disorders and Alzheimer's disease. JSM Alzheimer's Dis. Relat. Dement. 4, 1031.</Citation></Reference><Reference><Citation>Cort&#xe9;s N, Andrade V, Maccioni RB. 2018. Behavioral and neuropsychiatric disorders in Alzheimer's disease. J. Alzheimers Dis. 63, 899-910. (10.3233/JAD-180005)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180005</ArticleId><ArticleId IdType="pubmed">29710717</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias G, Cornejo A, Jimenez J, Guzman L, Maccioni RB. 2011. Mechanisms of tau self-aggregation and neurotoxicity. Curr. Alzheimer Res. 8, 608-614. (10.2174/156720511796717258)</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511796717258</ArticleId><ArticleId IdType="pubmed">21605046</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccioni RB, Munoz JP, Barbeito L. 2001. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch. Med. Res. 32, 367-381. (10.1016/S0188-4409(01)00316-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0188-4409(01)00316-2</ArticleId><ArticleId IdType="pubmed">11578751</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccioni RB. 2012. Introductory remarks. Molecular, biological and clinical aspects of Alzheimer's disease. Arch. Med. Res. 43, 593-594. (10.1016/j.arcmed.2012.11.001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2012.11.001</ArticleId><ArticleId IdType="pubmed">23149157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettens K, Sleegers K, Van Broeckhoven C. 2010. Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum. Mol. Genet. 19, R4-R11. (10.1093/hmg/ddq142)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq142</ArticleId><ArticleId IdType="pmc">PMC2875058</ArticleId><ArticleId IdType="pubmed">20388643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert JC, et al. 2009. Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 73, 847-853. (10.1212/WNL.0b013e3181b78448)</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b78448</ArticleId><ArticleId IdType="pubmed">19752451</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccioni RB, Rojo LE, Fernandez JA, RO Kuljis. 2009. The role of neuroimmunomodulation in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1153, 240-246. (10.1111/j.1749-6632.2008.03972.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2008.03972.x</ArticleId><ArticleId IdType="pubmed">19236346</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez JA, Rojo L, Kuljis RO, Maccioni RB. 2008. The damage signals hypothesis of Alzheimer's disease pathogenesis. J. Alzheimers Dis. 14, 329-333. (10.3233/JAD-2008-14307)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2008-14307</ArticleId><ArticleId IdType="pubmed">18599959</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P. 2015. Impact of insulin degrading enzyme and neprilysin in Alzheimer's disease biology: characterization of putative cognates for therapeutic applications. J. Alzheimers Dis. 48, 891-917. (10.3233/JAD-150379)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150379</ArticleId><ArticleId IdType="pubmed">26444774</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha NK, Jha SK, Sharma R, Kumar D, Ambasta RK, Kumar P. 2018. Hypoxia-induced signaling activation in neurodegenerative diseases: targets for new therapeutic strategies. J. Alzheimers Dis. 62, 15-38. (10.3233/JAD-170589)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170589</ArticleId><ArticleId IdType="pubmed">29439330</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo HN, Park JS, Gwon AR, Arumugam TV, Jo DG. 2009. Alzheimer's disease and Notch signaling. Biochem. Biophys. Res. Commun. 390, 1093-1097. (10.1016/j.bbrc.2009.10.093)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.10.093</ArticleId><ArticleId IdType="pubmed">19853579</ArticleId></ArticleIdList></Reference><Reference><Citation>Arumugam TV, et al. 2006. Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat. Med. 12, 621-623. (10.1038/nm1403)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1403</ArticleId><ArticleId IdType="pubmed">16680150</ArticleId></ArticleIdList></Reference><Reference><Citation>Brai E, Alina RN, Alberi L. 2016. Notch1 hallmarks fibrillary depositions in sporadic Alzheimer's disease. Acta Neuropathol. Commun. 4, 64-90. (10.1186/s40478-016-0327-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0327-2</ArticleId><ArticleId IdType="pmc">PMC4929714</ArticleId><ArticleId IdType="pubmed">27364742</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorobyeva AG, Saunders AJ. 2018. Amyloid-&#x3b2; interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure. Cilia 7, 5. (10.1186/s13630-018-0059-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13630-018-0059-y</ArticleId><ArticleId IdType="pmc">PMC6098584</ArticleId><ArticleId IdType="pubmed">30140428</ArticleId></ArticleIdList></Reference><Reference><Citation>Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP. 2002. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem. 83, 1509-1524. (10.1046/j.1471-4159.2002.01267.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01267.x</ArticleId><ArticleId IdType="pubmed">12472904</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. (10.1038/nature02621)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02621</ArticleId><ArticleId IdType="pmc">PMC3091392</ArticleId><ArticleId IdType="pubmed">15295589</ArticleId></ArticleIdList></Reference><Reference><Citation>Roper RJ, et al. 2006. Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc. Natl Acad. Sci. USA 103, 1452-1456. (10.1073/pnas.0510750103)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510750103</ArticleId><ArticleId IdType="pmc">PMC1360600</ArticleId><ArticleId IdType="pubmed">16432181</ArticleId></ArticleIdList></Reference><Reference><Citation>Trazzi S, Mitrugno VM, Valli E, Fuchs C, Rizzi S, Guidi S, Perini G, Bartesaghi R, Ciani E. 2011. APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. Hum. Mol. Genet. 20, 1560-1573. (10.1093/hmg/ddr033)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr033</ArticleId><ArticleId IdType="pubmed">21266456</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A. 2015. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat. Rev. Neurosci. 16, 564-574. (10.1038/nrn3983)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3983</ArticleId><ArticleId IdType="pmc">PMC4678594</ArticleId><ArticleId IdType="pubmed">26243569</ArticleId></ArticleIdList></Reference><Reference><Citation>He P, Staufenbiel M, Li R, Shen Y. 2014. Deficiency of patched 1-induced Gli1 signal transduction results in astrogenesis in Swedish mutated APP transgenic mice. Hum. Mol. Genet. 23, 6512-6527. (10.1093/hmg/ddu370)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu370</ArticleId><ArticleId IdType="pmc">PMC4296204</ArticleId><ArticleId IdType="pubmed">25027328</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JO, Karavanova ID, Williams KP, Mahanthappa NK, Allendoerfer KL. 2002. Cooperative effects of Sonic Hedgehog and NGF on basal forebrain cholinergic neurons. Mol. Cell. Neurosci. 19, 88-96. (10.1006/mcne.2001.1063)</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.2001.1063</ArticleId><ArticleId IdType="pubmed">11817900</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenivasmurthy SG, Liu JY, Song JX, Yang CB, Malampati S, Wang ZY, Huang YY, Li M. 2017. Neurogenic traditional Chinese medicine as a promising strategy for the treatment of Alzheimer's disease. Int. J. Mol. Sci. 18, 272. (10.3390/ijms18020272)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18020272</ArticleId><ArticleId IdType="pmc">PMC5343808</ArticleId><ArticleId IdType="pubmed">28134846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, et al. 1998. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702. (10.1038/27208)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/27208</ArticleId><ArticleId IdType="pubmed">9790190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper C, Killick R, Lovestone S. 2008. The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439. (10.1111/j.1471-4159.2007.05194.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05194.x</ArticleId><ArticleId IdType="pmc">PMC3073119</ArticleId><ArticleId IdType="pubmed">18088381</ArticleId></ArticleIdList></Reference><Reference><Citation>Scali C, et al. 2006. Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol. Dis. 24, 254-265. (10.1016/j.nbd.2006.06.016)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.06.016</ArticleId><ArticleId IdType="pubmed">16919965</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima A, et al. 1998. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl Acad. Sci. USA 95, 9637-9641. (10.1073/pnas.95.16.9637)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.16.9637</ArticleId><ArticleId IdType="pmc">PMC21391</ArticleId><ArticleId IdType="pubmed">9689133</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez A, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC. 2004. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 297, 186-196. (10.1016/j.yexcr.2004.02.028)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.02.028</ArticleId><ArticleId IdType="pubmed">15194435</ArticleId></ArticleIdList></Reference><Reference><Citation>Caricasole A, Copani A, Caruso A, Caraci F, Iacovelli L, Sortino MA, Terstappen GC, Nicoletti F. 2003. The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease? Trends Pharmacol. Sci. 24, 233-238. (10.1016/S0165-6147(03)00100-7)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(03)00100-7</ArticleId><ArticleId IdType="pubmed">12767722</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ferrari GV, et al. 2003. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatry 8, 195-208. (10.1038/sj.mp.4001208)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4001208</ArticleId><ArticleId IdType="pubmed">12610652</ArticleId></ArticleIdList></Reference><Reference><Citation>Caricasole A, et al. 2004. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J. Neurosci. 24, 6021-6027. (10.1523/JNEUROSCI.1381-04.2004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1381-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729239</ArticleId><ArticleId IdType="pubmed">15229249</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosi MC, et al. 2010. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J. Neurochem. 112, 1539-1551. (10.1111/j.1471-4159.2009.06566.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06566.x</ArticleId><ArticleId IdType="pubmed">20050968</ArticleId></ArticleIdList></Reference><Reference><Citation>Purro SA, Dickins EM, Salinas PC. 2012. The secreted Wnt antagonist Dickkopf-1 is required for amyloid-beta-mediated synaptic loss. J. Neurosci. 32, 3492-3498. (10.1523/JNEUROSCI.4562-11.2012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4562-11.2012</ArticleId><ArticleId IdType="pmc">PMC6621056</ArticleId><ArticleId IdType="pubmed">22399772</ArticleId></ArticleIdList></Reference><Reference><Citation>Purro SA, Galli S, Salinas PC. 2014. Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases. J. Mol. Cell Biol. 6, 75-80. (10.1093/jmcb/mjt049)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjt049</ArticleId><ArticleId IdType="pmc">PMC4344549</ArticleId><ArticleId IdType="pubmed">24449494</ArticleId></ArticleIdList></Reference><Reference><Citation>Killick R, et al. 2014. Clusterin regulates &#x3b2;-amyloid toxicity via Dickkopf-1-driven induction of the Wnt-PCP-JNK pathway. Mol. Psychiatry 19, 88-98. (10.1038/mp.2012.163)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.163</ArticleId><ArticleId IdType="pmc">PMC3873038</ArticleId><ArticleId IdType="pubmed">23164821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenzmaier C, Marksteiner J, Kiefer A, Berger P, Humpel C. 2009. Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients. J. Neurochem. 110, 653-661. (10.1111/j.1471-4159.2009.06158.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06158.x</ArticleId><ArticleId IdType="pmc">PMC4311140</ArticleId><ArticleId IdType="pubmed">19457090</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonen RA, van Tijn P, Zivkovic D. 2009. Wnt signaling in Alzheimer's disease: up or down, that is the question. Ageing Res. Rev. 8, 71-82. (10.1016/j.arr.2008.11.003)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2008.11.003</ArticleId><ArticleId IdType="pubmed">19101658</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso A, Motolese M, Iacovelli L, Caraci F, Copani A, Nicoletti F, Terstappen GC, Gaviraghi G, Caricasole A. 2006. Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J. Neurochem. 98, 364-371. (10.1111/j.1471-4159.2006.03867.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03867.x</ArticleId><ArticleId IdType="pubmed">16805831</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ferrari GV, et al. 2007. Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc. Natl Acad. Sci. USA 104, 9434-9439. (10.1073/pnas.0603523104)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603523104</ArticleId><ArticleId IdType="pmc">PMC1890512</ArticleId><ArticleId IdType="pubmed">17517621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia-Rojas C, Burgos PV, Inestrosa NC. 2016. Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid-beta (Abeta)42 peptides. J. Neurochem. 139, 1175-1191. (10.1111/jnc.13873)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13873</ArticleId><ArticleId IdType="pubmed">27778356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy ME, et al. 2016. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer's disease patients. Sci. Transl. Med. 8, 363ra150. (10.1126/scitranslmed.aad9704)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad9704</ArticleId><ArticleId IdType="pubmed">27807285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, et al. 2017. TREM2 promotes microglial survival by activating Wnt/beta-catenin pathway. J. Neurosci. 37, 1772-1784. (10.1523/JNEUROSCI.2459-16.2017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2459-16.2017</ArticleId><ArticleId IdType="pmc">PMC5320608</ArticleId><ArticleId IdType="pubmed">28077724</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Wan W, Xia S, Kalionis B, Li Y. 2014. Dysfunctional Wnt/&#x3b2;-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease. Neurochem. Int. 75, 19-25. (10.1016/j.neuint.2014.05.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2014.05.004</ArticleId><ArticleId IdType="pubmed">24859746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia-Rojas C, Lindsay CB, Montecinos-Oliva C, Arrazola MS, Retamales RM, Bunout D, Hirsch S, Inestrosa NC. 2015. Is L-methionine a trigger factor for Alzheimer's-like neurodegeneration? Changes in A&#x3b2; oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice. Mol. Neurodegener. 10, 62. (10.1186/s13024-015-0057-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0057-0</ArticleId><ArticleId IdType="pmc">PMC4654847</ArticleId><ArticleId IdType="pubmed">26590557</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha SK, Jha NK, Kar R, Ambasta RK, Kumar P. 2015. p38 MAPK and PI3 K/AKT signalling cascades in Parkinson's disease. Int. J. Mol. Cell Med. 4, 67-86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4499569</ArticleId><ArticleId IdType="pubmed">26261796</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves dos Santos MT, Smidt MP. 2011. En1 and Wnt signaling in midbrain dopaminergic neuronal development. Neural Dev. 6, 23. (10.1186/1749-8104-6-23)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8104-6-23</ArticleId><ArticleId IdType="pmc">PMC3104484</ArticleId><ArticleId IdType="pubmed">21569278</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DC, Harvey K. 2012. The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem. Soc. Trans. 40, 1123-1128. (10.1042/BST20120122)</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20120122</ArticleId><ArticleId IdType="pubmed">22988876</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephano F, Nolte S, Hoffmann J, El-Kholy S, von Frieling J, Bruchhaus I, Fink C, Roeder T. 2018. Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson's disease model. Sci. Rep. 8, 2372. (10.1038/s41598-018-20836-w)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20836-w</ArticleId><ArticleId IdType="pmc">PMC5799194</ArticleId><ArticleId IdType="pubmed">29403026</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DC, Harvey K. 2013. LRRK2: an &#xe9;minence grise of Wnt-mediated neurogenesis? Front. Cell. Neurosci. 7, 82. (10.3389/fncel.2013.00082)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00082</ArticleId><ArticleId IdType="pmc">PMC3668263</ArticleId><ArticleId IdType="pubmed">23754980</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma M, Steer EK, Chu CT. 2014. ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim. Biophys. Acta 1842, 1273-1281. (10.1016/j.bbadis.2013.11.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.11.005</ArticleId><ArticleId IdType="pmc">PMC4016799</ArticleId><ArticleId IdType="pubmed">24225420</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Deng J, Pan Q, Zhan Y, Fan JB, Zhang K, Zhang Z. 2016. Targeted methylation sequencing reveals dysregulated Wnt signaling in Parkinson disease. J. Genet. Genom. 43, 587-592. (10.1016/j.jgg.2016.05.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgg.2016.05.002</ArticleId><ArticleId IdType="pubmed">27692691</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, et al. 2015. The Parkinson's disease-associated protein kinase LRRK2 modulates Notch signaling through the endosomal pathway. PLoS Genet. 11, e1005503. (10.1371/journal.pgen.1005503)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005503</ArticleId><ArticleId IdType="pmc">PMC4565672</ArticleId><ArticleId IdType="pubmed">26355680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Reyes LE, et al. 2012. Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit. Neuron 75, 306-319. (10.1016/j.neuron.2012.05.018)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.05.018</ArticleId><ArticleId IdType="pmc">PMC3408586</ArticleId><ArticleId IdType="pubmed">22841315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JD, Liu N, Levin SC, Ottosson L, Andersson U, Harris HE, Woodruff TM. 2019. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neuroinflammation 16, 45. (10.1186/s12974-019-1435-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1435-2</ArticleId><ArticleId IdType="pmc">PMC6380064</ArticleId><ArticleId IdType="pubmed">30782181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guan Y, Liu H, Wu X, Yu L, Wang S, Zhao C, Du H, Wang X. 2012. Activation of the Wnt/beta-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem. Biophys. Res. Commun. 420, 397-403. (10.1016/j.bbrc.2012.03.006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.03.006</ArticleId><ArticleId IdType="pubmed">22426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guan Y, Zhang Z, Liu H, Wang S, Yu L, Wu X, Wang X. 2012. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol. Res. 34, 390-399. (10.1179/1743132812Y.0000000027)</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000027</ArticleId><ArticleId IdType="pubmed">22643084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Guan Y, Chen Y, Li X, Zhang C, Yu L, Zhou F, Wang X. 2013. Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice. Biotechnol. Lett. 35, 1199-1207. (10.1007/s10529-013-1199-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-013-1199-1</ArticleId><ArticleId IdType="pubmed">23553522</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Guan Y, Chen Y, Zhang C, Shi C, Zhou F, Yu L, Juan J, Wang X. 2013. Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice. Int. J. Clin. Exp. Pathol. 6, 1245-1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3693190</ArticleId><ArticleId IdType="pubmed">23826406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fern&#xe1;ndez C, Mancuso R, Del Valle J, Navarro X, Rodr&#xed;guez FJ. 2016. Wnt signaling alteration in the spinal cord of amyotrophic lateral sclerosis transgenic mice: special focus on frizzled-5 cellular expression pattern. PLoS ONE 11, e0155867. (10.1371/journal.pone.0155867)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155867</ArticleId><ArticleId IdType="pmc">PMC4871528</ArticleId><ArticleId IdType="pubmed">27192435</ArticleId></ArticleIdList></Reference><Reference><Citation>McLoon LK, Harandi VM, Brannstrom T, Andersen PM, Liu JX. 2014. Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis. Investig. Ophthalmol. Vis. Sci. 55, 5482-5496. (10.1167/iovs.14-14886)</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.14-14886</ArticleId><ArticleId IdType="pmc">PMC4580151</ArticleId><ArticleId IdType="pubmed">25125606</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C, Cardenas P, Osses N, Henriquez JP. 2013. Characterization of Wnt/beta-catenin and BMP/Smad signaling pathways in an in vitro model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 7, 239. (10.3389/fncel.2013.00239)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00239</ArticleId><ArticleId IdType="pmc">PMC3847560</ArticleId><ArticleId IdType="pubmed">24348333</ArticleId></ArticleIdList></Reference><Reference><Citation>Drannik A, Martin J, Peterson R, Ma X, Jiang F, Turnbull J. 2017. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function. PLoS ONE 12, e0171668. (10.1371/journal.pone.0171668)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171668</ArticleId><ArticleId IdType="pmc">PMC5295673</ArticleId><ArticleId IdType="pubmed">28170441</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Pinedo U, Gal&#xe1;n L, Mat&#xed;as-Guiu JA, Pytel V, Moreno T, Guerrero-Sola A, Mat&#xed;as-Guiu J. 2019. Notch signalling in the hippocampus of patients with motor neuron disease. Front. Neurosci. 13, 302. (10.3389/fnins.2019.00302)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00302</ArticleId><ArticleId IdType="pmc">PMC6460507</ArticleId><ArticleId IdType="pubmed">31024234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonneman A, et al. 2018. Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis. Neurobiol. Dis. 119, 26-40. (10.1016/j.nbd.2018.07.012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.012</ArticleId><ArticleId IdType="pubmed">30010003</ArticleId></ArticleIdList></Reference><Reference><Citation>Folestad A, Alund M, Asteberg S, Fowelin J, Aurell Y, Gothlin J, Cassuto J. 2015. Role of Wnt/beta-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. Acta Orthop. 86, 415-425. (10.3109/17453674.2015.1033606)</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453674.2015.1033606</ArticleId><ArticleId IdType="pmc">PMC4513595</ArticleId><ArticleId IdType="pubmed">25811776</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusse R. 2008. Wnt signaling and stem cell control. Cell Res. 18, 523-527. (10.1038/cr.2008.47)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2008.47</ArticleId><ArticleId IdType="pubmed">18392048</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. 2002. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 21, 281-293. (10.1093/emboj/21.3.281)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.3.281</ArticleId><ArticleId IdType="pmc">PMC125832</ArticleId><ArticleId IdType="pubmed">11823421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen P, Frame S. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol 2, 769-776. (10.1038/35096075)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35096075</ArticleId><ArticleId IdType="pubmed">11584304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. 1992. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62. (10.1016/0304-3940(92)90774-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(92)90774-2</ArticleId><ArticleId IdType="pubmed">1336152</ArticleId></ArticleIdList></Reference><Reference><Citation>King MR, Anderson NJ, Liu C, Law E, Cundiff M, Mixcoatl-Zecuatl TM, Jolivalt CG. 2015. Activation of the insulin-signaling pathway in sciatic nerve and hippocampus of type 1 diabetic rats. Neuroscience 303, 220-228. (10.1016/j.neuroscience.2015.06.060)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.06.060</ArticleId><ArticleId IdType="pmc">PMC4532558</ArticleId><ArticleId IdType="pubmed">26149351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzardo-Martins L, Martins DF, Stramosk J, Cidral-Filho FJ, Santos AR. 2012. Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action. Neuroscience 226, 411-420. (10.1016/j.neuroscience.2012.09.020)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.09.020</ArticleId><ArticleId IdType="pubmed">23000630</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, Chen Y, Woodgett JR, Li M. 2010. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J. Biol. Chem. 285, 41 122-41 134. (10.1074/jbc.M110.130351)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.130351</ArticleId><ArticleId IdType="pmc">PMC3003410</ArticleId><ArticleId IdType="pubmed">20841359</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ma L, Chen X, Li Y, Li S, Zhang J, Lu L. 2014. Glycogen synthase kinase-3: a key kinase in retinal neuron apoptosis in early diabetic retinopathy. Chin. Med. J. 127, 3464-3470.</Citation><ArticleIdList><ArticleId IdType="pubmed">25269915</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolivalt CG, Calcutt NA, Masliah E. 2012. Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease. Neuroscience 202, 405-412. (10.1016/j.neuroscience.2011.11.032)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.11.032</ArticleId><ArticleId IdType="pmc">PMC3268846</ArticleId><ArticleId IdType="pubmed">22178988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong QX, Xu SY, Dai SH, Zhao WX. 2016. Expression profiling of spinal genes in peripheral neuropathy model rats with type 2 diabetes mellitus. Int. J. Clin. Exp. Med. 9, 6376-6384.</Citation></Reference><Reference><Citation>Cheng PW, et al. 2015. Wnt signaling regulates blood pressure by downregulating a GSK-3beta-mediated pathway to enhance insulin signaling in the central nervous system. Diabetes 64, 3413-3424. (10.2337/db14-1439)</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1439</ArticleId><ArticleId IdType="pubmed">25883115</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Zhong W, Duan A, Sun G, Cui W, Zhuang X, Liu L. 2019. Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: an unresolved issue. Pharm. Res. 144, 151-157. (10.1016/j.phrs.2019.03.022)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.03.022</ArticleId><ArticleId IdType="pubmed">30935943</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y. 2009. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J. Am. Soc. Nephrol. 20, 1997-2008. (10.1681/ASN.2009010019)</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009010019</ArticleId><ArticleId IdType="pmc">PMC2736766</ArticleId><ArticleId IdType="pubmed">19628668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CL, Cheng H, Tung CW, Huang WJ, Chang PJ, Yang JT, Wang JY. 2008. Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. Am. J. Nephrol. 28, 290-297. (10.1159/000111142)</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000111142</ArticleId><ArticleId IdType="pubmed">18004065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho C, Lee PH, Hsu YC, Wang FS, Huang YT, Lin CL. 2012. Sustained Wnt/beta-catenin signaling rescues high glucose induction of transforming growth factor-beta1-mediated renal fibrosis. Am. J. Med. Sci. 344, 374-382. (10.1097/MAJ.0b013e31824369c5)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0b013e31824369c5</ArticleId><ArticleId IdType="pubmed">22270399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Han HJ. 2010. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3 K/Akt, GSK-3beta, Snail1, and beta-catenin in renal proximal tubule cells. Am. J. Physiol. Ren. Physiol. 298, F1263-F1275. (10.1152/ajprenal.00475.2009)</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00475.2009</ArticleId><ArticleId IdType="pubmed">20015942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou XR, Wang XQ, Hu YL, Zhou HL. 2016. Effects of Shen'an granules on Wnt signaling pathway in mouse models of diabetic nephropathy. Exp. Ther. Med. 12, 3515-3520. (10.3892/etm.2016.3800)</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3800</ArticleId><ArticleId IdType="pmc">PMC5228428</ArticleId><ArticleId IdType="pubmed">28105085</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Wang M, Yang S, Liu F, Sun L. 2013. A glimpse of the pathogenetic mechanisms of Wnt/beta-catenin signaling in diabetic nephropathy. BioMed Res. Int. 2013, 987064. (10.1155/2013/987064)</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/987064</ArticleId><ArticleId IdType="pmc">PMC3886614</ArticleId><ArticleId IdType="pubmed">24455745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapouly C, Yao Q, Vandierdonck S, Larrieu-Lahargue F, Mariani JN, Gadeau AP, Renault MA. 2016. Impaired Hedgehog signalling-induced endothelial dysfunction issufficient to induce neuropathy: implication in diabetes. Cardiovasc. Res. 109, 217-227. (10.1093/cvr/cvv263)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvv263</ArticleId><ArticleId IdType="pubmed">26645982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, et al. 2017. Fluoride induces neuroinflammation and alters Wnt signaling pathway in BV2 microglial cells. Inflammation 40, 1123-1130. (10.1007/s10753-017-0556-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0556-y</ArticleId><ArticleId IdType="pubmed">28405851</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomer E, Buechler J, Salinas PC. 2019. Wnt signaling deregulation in the aging and Alzheimer's brain. Front. Cell. Neurosci. 13, 227. (10.3389/fncel.2019.00227)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00227</ArticleId><ArticleId IdType="pmc">PMC6538920</ArticleId><ArticleId IdType="pubmed">31191253</ArticleId></ArticleIdList></Reference><Reference><Citation>Raychaudhuri M, Mukhopadhyay D. 2011. AICD overexpression in neuro 2A cells regulates expression of PTCH1 and TRPC5. Int. J. Alzheimers Dis. 2011, 239453. (10.4061/2011/239453)</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/239453</ArticleId><ArticleId IdType="pmc">PMC2935165</ArticleId><ArticleId IdType="pubmed">20827383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Turnbull P, Peterson R, Turnbull J. 2013. Trophic and proliferative effects of Shh on motor neurons in embryonic spinal cord culture from wildtype and G93A SOD1 mice. BMC Neurosci. 14, 119. (10.1186/1471-2202-14-119)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-14-119</ArticleId><ArticleId IdType="pmc">PMC3852546</ArticleId><ArticleId IdType="pubmed">24119209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hester ME, et al. 2011. Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol. Ther. 19, 1905-1912. (10.1038/mt.2011.135)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2011.135</ArticleId><ArticleId IdType="pmc">PMC3188742</ArticleId><ArticleId IdType="pubmed">21772256</ArticleId></ArticleIdList></Reference><Reference><Citation>Umamaheshwar KL, Sehrawat A, Parashar MK, Mavade K. 2013. Two case reports of an unusual association between Klippel-Feil syndrome and amyotrophic lateral sclerosis: do they share same genetic defect? Ann. Indian Acad. Neurol. 16, 705-707. (10.4103/0972-2327.120456)</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-2327.120456</ArticleId><ArticleId IdType="pmc">PMC3841637</ArticleId><ArticleId IdType="pubmed">24339616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega JA, Radonji&#x107; NV, Zecevic N. 2013. Sonic hedgehog promotes generation and maintenance of human forebrain Olig2 progenitors. Front. Cell. Neurosci. 7, 254. (10.3389/fncel.2013.00254)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00254</ArticleId><ArticleId IdType="pmc">PMC3861791</ArticleId><ArticleId IdType="pubmed">24379757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Imitola J, Rasmussen S, O'Connor KC, Khoury SJ. 2008. Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog-Gli1 in autoimmune encephalomyelitis and multiple sclerosis. Ann. Neurol. 64, 417-427. (10.1002/ana.21457)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21457</ArticleId><ArticleId IdType="pmc">PMC2757750</ArticleId><ArticleId IdType="pubmed">18991353</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Wang Z, Tchantchou F, Chiu C, Zhang Y, Chuang D. 2012. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J. Neurotrauma 29, 362-374. (10.1089/neu.2011.1942)</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.1942</ArticleId><ArticleId IdType="pmc">PMC3261788</ArticleId><ArticleId IdType="pubmed">21895523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont P, Besson MT, Devaux J, Li&#xe9;vens JC. 2012. Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila. Neurobiol. Dis. 47, 237-247. (10.1016/j.nbd.2012.04.007)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.04.007</ArticleId><ArticleId IdType="pubmed">22531500</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, et al. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16, 243-251. (10.1038/ng0797-243)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0797-243</ArticleId><ArticleId IdType="pubmed">9207788</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasky JL, Wu H. 2005. Notch signaling, brain development, and human disease. Pediatr. Res. 57, 104R-109R. (10.1203/01.PDR.0000159632.70510.3D)</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.PDR.0000159632.70510.3D</ArticleId><ArticleId IdType="pubmed">15817497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Takagi N, Nakahara M, Takeo S. 2005. Changes in the expression of Hes5 and Mash1 mRNA in the adult rat dentate gyrus after transient forebrain ischemia. Neurosci. Lett. 380, 17-20. (10.1016/j.neulet.2005.01.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.01.005</ArticleId><ArticleId IdType="pubmed">15854743</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson MV, et al. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9, 617-628. (10.1016/j.devcel.2005.09.010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2005.09.010</ArticleId><ArticleId IdType="pubmed">16256737</ArticleId></ArticleIdList></Reference><Reference><Citation>Androutsellis-Theotokis A, et al. 2006. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442, 823-826. (10.1038/nature04940)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04940</ArticleId><ArticleId IdType="pubmed">16799564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T, Raff M. 2000. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 127, 2989-2998. (10.1242/dev.127.14.2989)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.127.14.2989</ArticleId><ArticleId IdType="pubmed">10862737</ArticleId></ArticleIdList></Reference><Reference><Citation>Genoud S, Lappe-Siefke C, Goebbels S, Radtke F, Aguet M, Scherer SS, Suter U, Nave KA, Mantei N. 2002. Notch1 control of oligodendrocyte differentiation in the spinal cord. J. Cell Biol. 158, 709-718. (10.1083/jcb.200202002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200202002</ArticleId><ArticleId IdType="pmc">PMC2174019</ArticleId><ArticleId IdType="pubmed">12186854</ArticleId></ArticleIdList></Reference><Reference><Citation>Givogri MI, Costa RM, Schonmann V, Silva AJ, Campagnoni AT, Bongarzone ER. 2002. Central nervous system myelination in mice with deficient expression of notch1 receptor. J. Neurosci. Res. 67, 309-320. (10.1002/jnr.10128)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10128</ArticleId><ArticleId IdType="pubmed">11813235</ArticleId></ArticleIdList></Reference><Reference><Citation>John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF. 2002. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8, 1115-1121. (10.1038/nm781)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm781</ArticleId><ArticleId IdType="pubmed">12357247</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurynczyk M, Jurewicz A, Bielecki B, Raine CS, Selmaj K. 2005. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J. Neuroimmunol. 170, 3-10. (10.1016/j.jneuroim.2005.10.013)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2005.10.013</ArticleId><ArticleId IdType="pubmed">16290267</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifert T, Bauer J, Weissert R, Fazekas F, Storch MK. 2007. Notch1 and its ligand Jagged1 are present in remyelination in a T cell- and antibody-mediated model of inflammatory demyelination. Acta Neuropathol. 113, 195-203. (10.1007/s00401-006-0170-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0170-9</ArticleId><ArticleId IdType="pubmed">17136549</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubert G, Minana R, Pascual M, Guerri C. 2006. Ethanol exposure during embryogenesis decreases the radial glial progenitor pool and affects the generation of neurons and astrocytes. J. Neurosci. Res. 84, 483-496. (10.1002/jnr.20963)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20963</ArticleId><ArticleId IdType="pubmed">16770775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagarsheth MH, Viehman A, Lippa SM, Lippa CF. 2006. Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease. J. Neurol. Sci. 244, 111-116. (10.1016/j.jns.2006.01.007)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.01.007</ArticleId><ArticleId IdType="pubmed">16473372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding XF, et al. 2014. Postnatal dysregulation of Notch signal disrupts dendrite development of adult-born neurons in the hippocampus and contributes to memory impairment. Sci. Rep. 6, 25780. (10.1038/srep25780)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25780</ArticleId><ArticleId IdType="pmc">PMC4865733</ArticleId><ArticleId IdType="pubmed">27173138</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie K, Qiao F, Sun Y, Wang G, Hou L. 2015. Notch signaling activation is critical to the development of neuropathic pain. BMC Anesthesiol. 15, 41. (10.1186/s12871-015-0021-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-015-0021-0</ArticleId><ArticleId IdType="pmc">PMC4377217</ArticleId><ArticleId IdType="pubmed">25821407</ArticleId></ArticleIdList></Reference><Reference><Citation>Belinson H, et al. 2016. Prenatal beta-catenin/Brn2/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors. Mol. Psychiatry 21, 1417-1433. (10.1038/mp.2015.207)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.207</ArticleId><ArticleId IdType="pmc">PMC5685528</ArticleId><ArticleId IdType="pubmed">26830142</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervo d, et al. 2017. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nat. Biotechnol. 35, 444-452. (10.1038/nbt.3835)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3835</ArticleId><ArticleId IdType="pubmed">28398344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehyai S, Miyake T, Williams D, Vinayak J, Bayfield MA, McDermott JC. 2018. FMRP recruitment of &#x3b2;-catenin to the translation pre-initiation complex represses translation. EMBO Rep. 19, e45536. (10.15252/embr.201745536)</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201745536</ArticleId><ArticleId IdType="pmc">PMC6280795</ArticleId><ArticleId IdType="pubmed">30361391</ArticleId></ArticleIdList></Reference><Reference><Citation>L'Episcopo F, et al. 2011. Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiol. Dis. 41, 508-527. (10.1016/j.nbd.2010.10.023)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.10.023</ArticleId><ArticleId IdType="pmc">PMC3558878</ArticleId><ArticleId IdType="pubmed">21056667</ArticleId></ArticleIdList></Reference><Reference><Citation>L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Serapide MF, Pluchino S, Marchetti B. 2014. Wnt/beta-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease. Stem Cells 32, 2147-2163. (10.1002/stem.1708)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1708</ArticleId><ArticleId IdType="pmc">PMC4106883</ArticleId><ArticleId IdType="pubmed">24648001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales-Reynoso MA, Ochoa-Hernandez AB, Aguilar-Lemarroy A, Jave-Suarez LF, Troyo-Sanroman R, Barros-Nunez P. 2010. Gene expression profiling identifies WNT7A as a possible candidate gene for decreased cancer risk in fragile X syndrome patients. Arch. Med. Res. 41, 110-118. (10.1016/j.arcmed.2010.03.001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2010.03.001</ArticleId><ArticleId IdType="pubmed">20470940</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro MR, Bray SM, Warren ST. 2012. Molecular mechanisms of Fragile X syndrome: a twenty-year perspective. Annu. Rev. Pathol. 7, 219-245. (10.1146/annurev-pathol-011811-132457)</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-011811-132457</ArticleId><ArticleId IdType="pubmed">22017584</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd PK, Malter JS. 2002. Fragile X mental retardation protein in plasticity and disease. J. Neurosci. Res. 70, 623-630. (10.1002/jnr.10453)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10453</ArticleId><ArticleId IdType="pubmed">12424729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A, Shen CH, Ma SY, Ke Y, El Idrissi A. 2009. Altered expression of Autism-associated genes in the brain of Fragile X mouse model. Biochem. Biophys. Res. Commun. 379, 920-923. (10.1016/j.bbrc.2008.12.172)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.12.172</ArticleId><ArticleId IdType="pubmed">19138667</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW. 2003. The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med. 35, 86-93. (10.1080/07853890310010005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890310010005</ArticleId><ArticleId IdType="pubmed">12795338</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyaoka T, Seno H, Ishino H. 1999. Increased expression of Wnt-1 in schizophrenic brains. Schizophr. Res. 38, 1-6. (10.1016/S0920-9964(98)00179-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0920-9964(98)00179-0</ArticleId><ArticleId IdType="pubmed">10427605</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman PE, et al. 2018. Highly conserved molecular pathways, including Wnt signaling, promote functional recovery from spinal cord injury in lampreys. Sci. Rep. 8, 742. (10.1038/s41598-017-18757-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18757-1</ArticleId><ArticleId IdType="pmc">PMC5768751</ArticleId><ArticleId IdType="pubmed">29335507</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu T, et al. 2003. The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia. Neurosci. Lett. 353, 53-56. (10.1016/j.neulet.2003.09.017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2003.09.017</ArticleId><ArticleId IdType="pubmed">14642436</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva CA, Montecinos-Oliva C, Inestrosa NC. 2018. Wnt signaling in the central nervous system: new insights in health and disease. Prog. Mol. Biol. Transl. Sci. 153, 81-130. (10.1016/bs.pmbts.2017.11.018)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2017.11.018</ArticleId><ArticleId IdType="pubmed">29389523</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachter KA, Krauss RS. 2008. Murine models of holoprosencephaly. Curr. Top. Dev. Biol. 84, 139-170. (10.1016/S0070-2153(08)00603-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0070-2153(08)00603-0</ArticleId><ArticleId IdType="pubmed">19186244</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerpa W, Farias GG, Godoy JA, Fuenzalida M, Bonansco C, Inestrosa NC. 2010. Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol. Neurodegener. 5, 3. (10.1186/1750-1326-5-3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-5-3</ArticleId><ArticleId IdType="pmc">PMC2823745</ArticleId><ArticleId IdType="pubmed">20205789</ArticleId></ArticleIdList></Reference><Reference><Citation>Couti&#xf1;o L, Godoy JA, Couve A, Fuenzalida M, Inestrosa NC. 2010. Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. J. Neurosci. 30, 8411-8420. (10.1523/JNEUROSCI.5736-09.2010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5736-09.2010</ArticleId><ArticleId IdType="pmc">PMC6634644</ArticleId><ArticleId IdType="pubmed">20573888</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias GG, Alfaro IE, Cerpa W, Grabowski CP, Godoy JA, Bonansco C, Inestrosa NC. 2009. Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. J. Biol. Chem. 284, 15 857-15 866. (10.1074/jbc.M808986200)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M808986200</ArticleId><ArticleId IdType="pmc">PMC2708882</ArticleId><ArticleId IdType="pubmed">19332546</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz FJ, Godoy JA, Cerpa W, Poblete IM, Huidobro-Toro JP, Inestrosa NC. 2014. Wnt-5a increases NO and modulates NMDA receptor in rat hippocampal neurons. Biochem. Biophys. Res. Commun. 444, 189-194. (10.1016/j.bbrc.2014.01.031)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.01.031</ArticleId><ArticleId IdType="pubmed">24440698</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela-Nallar L, Alfaro IE, Serrano FG, Parodi J, Inestrosa NC. 2010. Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc. Natl Acad. Sci. USA 107, 21 164-21 169. (10.1073/pnas.1010011107)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010011107</ArticleId><ArticleId IdType="pmc">PMC3000271</ArticleId><ArticleId IdType="pubmed">21084636</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng H, Chopp M, Hozeska-Solgot A, Shen L, Lu M, Tang C, Zhang ZG. 2012. Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis. PLoS ONE 7, e33444. (10.1371/journal.pone.0033444)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033444</ArticleId><ArticleId IdType="pmc">PMC3303815</ArticleId><ArticleId IdType="pubmed">22432023</ArticleId></ArticleIdList></Reference><Reference><Citation>Blurton-Jones M, et al. 2009. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl Acad. Sci. USA 106, 13 594-13 599. (10.1073/pnas.0901402106)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0901402106</ArticleId><ArticleId IdType="pmc">PMC2715325</ArticleId><ArticleId IdType="pubmed">19633196</ArticleId></ArticleIdList></Reference><Reference><Citation>Criscuolo C, Fabiani C, Bonadonna C, Origlia N, Domenici L. 2015. BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation. Neurobiol. Aging 36, 1303-1309. (10.1016/j.neurobiolaging.2014.11.016)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.11.016</ArticleId><ArticleId IdType="pubmed">25554494</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y, Negishi T, Inoue M, Tashiro T, Tabira T, Kimura N. 2012. Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer's disease. J. Neurosci. Res. 90, 981-989. (10.1002/jnr.22830)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22830</ArticleId><ArticleId IdType="pubmed">22252710</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Pitta M, Jiang H, Lee JH, Zhang G, Chen X, Kawamoto EM, Mattson MP. 2013. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol. Aging 34, 1564-1580. (10.1016/j.neurobiolaging.2012.11.020)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.11.020</ArticleId><ArticleId IdType="pmc">PMC3596471</ArticleId><ArticleId IdType="pubmed">23273573</ArticleId></ArticleIdList></Reference><Reference><Citation>Marosi K, Mattson MP. 2014. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 25, 89-98. (10.1016/j.tem.2013.10.006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2013.10.006</ArticleId><ArticleId IdType="pmc">PMC3915771</ArticleId><ArticleId IdType="pubmed">24361004</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA. 2013. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983-997. (10.1038/nm.3232)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3232</ArticleId><ArticleId IdType="pubmed">23921753</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhao B, Xiong X, Xia Z. 2018. The neuroprotective roles of sonic hedgehog signaling pathway in ischemic stroke. Neurochem. Res. 43, 2199-2211. (10.1007/s11064-018-2645-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2645-1</ArticleId><ArticleId IdType="pubmed">30267379</ArticleId></ArticleIdList></Reference><Reference><Citation>Carl&#xe9;n M, et al. 2009. Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat. Neurosci. 12, 259-267. (10.1038/nn.2268)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2268</ArticleId><ArticleId IdType="pubmed">19234458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chopp M, Zhang RL, Zhang L, Letourneau Y, Feng YF, Jiang A, Morris DC, Zhang ZG. 2009. The Notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke. Neuroscience 158, 1356-1363. (10.1016/j.neuroscience.2008.10.064)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.10.064</ArticleId><ArticleId IdType="pmc">PMC2757073</ArticleId><ArticleId IdType="pubmed">19059466</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao MJ, Han Z, Shao B, Jin K. 2009. Notch signaling and neuro-genesis in normal and stroke brain. Int. J. Physiol. Pathophysiol. Pharmacol. 1, 192-202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860305</ArticleId><ArticleId IdType="pubmed">20428478</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Liu LY, Ma YY, Zhang W. 2014. Notch signaling-mediated neural lineage selection facilitates intrastriatal transplantation therapy for ischemic stroke by promoting endogenous regeneration in the hippocampus. Cell Transplant. 23, 221-238. (10.3727/096368912X661355)</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368912X661355</ArticleId><ArticleId IdType="pubmed">23295012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharek A, Chen J, Cui X, Yang Y, Chopp M. 2009. Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke 40, 254-260. (10.1161/STROKEAHA.108.524116)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.524116</ArticleId><ArticleId IdType="pmc">PMC2804086</ArticleId><ArticleId IdType="pubmed">18927449</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Alvarez C, Arrazola MS, Godoy JA, Ordenes D, Inestrosa NC. 2013. Canonical Wnt signaling protects hippocampal neurons from Abeta oligomers: role of non-canonical Wnt-5a/Ca2+ in mitochondrial dynamics. Front. Cell Neurosci. 7, 97. (10.3389/fncel.2013.00097)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00097</ArticleId><ArticleId IdType="pmc">PMC3691552</ArticleId><ArticleId IdType="pubmed">23805073</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas J, Fuenzalida M, Inestrosa NC. 2014. In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model. J. Neurosci. 34, 2191-2202. (10.1523/JNEUROSCI.0862-13.2014)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0862-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608527</ArticleId><ArticleId IdType="pubmed">24501359</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Varela-Nallar L. 2014. Wnt signaling in the nervous system and in Alzheimer's disease. J. Mol. Cell Biol. 6, 64-74. (10.1093/jmcb/mjt051)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjt051</ArticleId><ArticleId IdType="pubmed">24549157</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Toledo EM. 2008. The role of Wnt signaling in neuronal dysfunction in Alzheimer's disease. Mol. Neurodegener. 3, 9. (10.1186/1750-1326-3-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-3-9</ArticleId><ArticleId IdType="pmc">PMC2515306</ArticleId><ArticleId IdType="pubmed">18652670</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Arenas E. 2010. Emerging roles of Wnts in the adult nervous system. Nat. Rev. Neurosci. 11, 77-86. (10.1038/nrn2755)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2755</ArticleId><ArticleId IdType="pubmed">20010950</ArticleId></ArticleIdList></Reference><Reference><Citation>Speese SD, Budnik V. 2007. Wnts: Up-and-coming at the synapse. Trends Neurosci. 30, 268-275. (10.1016/j.tins.2007.04.003)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2007.04.003</ArticleId><ArticleId IdType="pmc">PMC3499976</ArticleId><ArticleId IdType="pubmed">17467065</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen M, Hoerndli FJ, Brockie PJ, Wang R, Johnson E, Maxfield D, Francis MM, Madsen DM, Maricq AV. 2012. Wnt signaling regulates acetylcholine receptor translocation and synaptic plasticity in the adult nervous system. Cell 149, 173-187. (10.1016/j.cell.2011.12.038)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.12.038</ArticleId><ArticleId IdType="pmc">PMC3375111</ArticleId><ArticleId IdType="pubmed">22464329</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvajal FJ, Zolezzi JM, Tapia-Rojas C, Godoy JA, Inestrosa NC. 2013. Tetrahydrohyperforin decreases cholinergic markers associated with amyloid-beta plaques, 4-hydroxynonenal formation, and caspase-3 activation in AbetaPP/PS1 mice. J. Alzheimers Dis. 36, 99-118. (10.3233/JAD-130230)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-130230</ArticleId><ArticleId IdType="pubmed">23568104</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusse R, Varmus H. 2012. Three decades of Wnts; a personal perspective on how a scientific field developed. EMBO J. 31, 2670-2682. (10.1038/emboj.2012.146)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.146</ArticleId><ArticleId IdType="pmc">PMC3380217</ArticleId><ArticleId IdType="pubmed">22617420</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Godoy JA, Vargas JY, Arrazola MS, Rios JA, Carvajal FJ, Serrano FG, Farias GG. 2013. Nicotine prevents synaptic impairment induced by amyloid-&#x3b2; oligomers through &#x3b1;7-nicotinic acetylcholine receptor activation. Neuromolecular Med. 15, 549-569. (10.1007/s12017-013-8242-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-013-8242-1</ArticleId><ArticleId IdType="pubmed">23842742</ArticleId></ArticleIdList></Reference><Reference><Citation>Clevers H, Nusse R. 2012. Wnt/&#x3b2;-catenin signaling and disease. Cell 149, 1192-1205. (10.1016/j.cell.2012.05.012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.05.012</ArticleId><ArticleId IdType="pubmed">22682243</ArticleId></ArticleIdList></Reference><Reference><Citation>Proweller A, Wright AC, Horng D, Cheng L, Lu MM, Lepore JJ, Pear WS, Parmacek MS. 2007. Notch signaling in vascular smooth muscle cells is required to pattern the cerebral vasculature. Proc. Natl Acad. Sci. USA 104, 16 275-16 280. (10.1073/pnas.0707950104)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0707950104</ArticleId><ArticleId IdType="pmc">PMC2042197</ArticleId><ArticleId IdType="pubmed">17909179</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyttendaele H, Closson V, Wu G, Roux F, Weinmaster G, Kitajewski J. 2000. Notch4 and Jagged-1 induce microvessel differentiation of rat brain endothelial cells. Microvasc. Res. 60, 91-103. (10.1006/mvre.2000.2254)</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mvre.2000.2254</ArticleId><ArticleId IdType="pubmed">10964583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambakidis NC, Petrullis M, Kui X, Rothstein B, Karampelas I, Kuang Y, Selman WR, LaManna JC, Miller RH. 2012. Improvement of neurological recovery and stimulation of neural progenitor cell proliferation by intrathecal administration of Sonic hedgehog. J. Neurosurg. 116, 1114-1120. (10.3171/2012.1.JNS111285)</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2012.1.JNS111285</ArticleId><ArticleId IdType="pubmed">22324418</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SS, et al. 2013. Anti-oxidative, anti-apoptotic, and pro-angiogenic effects mediate functional improvement by sonic hedgehog against focal cerebral ischemia in rats. Exp. Neurol. 247, 680-688. (10.1016/j.expneurol.2013.03.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.03.004</ArticleId><ArticleId IdType="pubmed">23499832</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuboi K, Shults CW. 2002. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease. Exp. Neurol. 173, 95-104. (10.1006/exnr.2001.7825)</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7825</ArticleId><ArticleId IdType="pubmed">11771942</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M, Liang Y, Chen H, Xu B, Chai C, Xing P. 2018. The role of fluoxetine in activating Wnt/&#x3b2;-catenin signaling and repressing &#x3b2;-amyloid production in an Alzheimer mouse model. Front. Aging Neurosci. 10, 164. (10.3389/fnagi.2018.00164)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00164</ArticleId><ArticleId IdType="pmc">PMC5992518</ArticleId><ArticleId IdType="pubmed">29910725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari SK, et al. 2014. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/&#x3b2;-catenin pathway. ACS Nano 8, 76-103. (10.1021/nn405077y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/nn405077y</ArticleId><ArticleId IdType="pubmed">24467380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan W, Xia S, Kalionis B, Liu L, Li Y. 2014. The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target? Biomed. Res. Int. 2014, 301575. (10.1155/2014/301575)</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/301575</ArticleId><ArticleId IdType="pmc">PMC4026919</ArticleId><ArticleId IdType="pubmed">24883305</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Varela-Nallar L, Grabowski CP, Colombres M. 2007. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target. IUBMB Life 59, 316-321. (10.1080/15216540701242490)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15216540701242490</ArticleId><ArticleId IdType="pubmed">17505971</ArticleId></ArticleIdList></Reference><Reference><Citation>Far&#xed;as GG, Godoy JA, V&#xe1;zquez MC, Adani R, Meshulam H, Avila J, Amitai G, Inestrosa NC. 2005. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components. Neurobiol. Dis. 18, 176-183. (10.1016/j.nbd.2004.09.012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2004.09.012</ArticleId><ArticleId IdType="pubmed">15649708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY, Zheng W, Wang T, Xie JW, Wang SL, Zhao BL, Teng WP, Wang ZY. 2011. Huperzine A activates Wnt/&#x3b2;-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology 36, 1073-1089. (10.1038/npp.2010.245)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2010.245</ArticleId><ArticleId IdType="pmc">PMC3077275</ArticleId><ArticleId IdType="pubmed">21289607</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M. 2005. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling. Exp. Cell Res. 304, 91-104. (10.1016/j.yexcr.2004.09.032)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.09.032</ArticleId><ArticleId IdType="pubmed">15707577</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo EM, Inestrosa NC. 2010. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol. Psychiatry 15, 272-285. (10.1038/mp.2009.72)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2009.72</ArticleId><ArticleId IdType="pubmed">19621015</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano FG, Tapia-Rojas C, Carvajal FJ, Hancke J, Cerpa W, Inestrosa NC. 2014. Andrographolide reduces cognitive impairment in young and mature AbetaPPswe/PS-1 mice. Mol. Neurodegener. 9, 61. (10.1186/1750-1326-9-61)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-61</ArticleId><ArticleId IdType="pmc">PMC4414355</ArticleId><ArticleId IdType="pubmed">25524173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha A, et al. 2015. Neuroprotective role of Novel triazine derivatives by activating Wnt/&#x3b2; catenin signaling pathway in rodent models of Alzheimer's disease. Mol. Neurobiol. 52, 638-652. (10.1007/s12035-014-8899-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8899-y</ArticleId><ArticleId IdType="pubmed">25257697</ArticleId></ArticleIdList></Reference><Reference><Citation>Machhi J, et al. 2016. Neuroprotective potential of novel multi-targeted isoalloxazine derivatives in rodent models of Alzheimer's disease through activation of canonical Wnt/&#x3b2;-catenin signalling pathway. Neurotox. Res. 29, 495-513. (10.1007/s12640-016-9598-4)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-016-9598-4</ArticleId><ArticleId IdType="pubmed">26797524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Yang JW, Kim KH, Kim JU, Yook TH. 2019. A review on studies of Marijuana for Alzheimer's disease - focusing on CBD, THC. J. Pharmacopuncture 22, 225-230. (10.3831/KPI.2019.22.030)</Citation><ArticleIdList><ArticleId IdType="doi">10.3831/KPI.2019.22.030</ArticleId><ArticleId IdType="pmc">PMC6970569</ArticleId><ArticleId IdType="pubmed">31970019</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e A, Lecarpentier Y, Guillevin R, Vall&#xe9;e J. 2017. Effects of cannabidiol interactions with Wnt/&#x3b2;-catenin pathway and PPAR&#x3b3; on oxidative stress and neuroinflammation in Alzheimer's disease. Acta Biochim. Biophys. Sin. 49, 853-866. (10.1093/abbs/gmx073)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmx073</ArticleId><ArticleId IdType="pubmed">28981597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YL, et al. 2017. Protective effect of curcumin against oxidative stress-induced injury in rats with Parkinson's disease through the Wnt/&#x3b2;-catenin signaling pathway. Cell Physiol. Biochem. 43, 2226-2241. (10.1159/000484302)</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484302</ArticleId><ArticleId IdType="pubmed">29069652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamarehei M, Yazdanparast R, Aghazadeh S. 2014. Curcumin protects SK-N-MC cells from H2O2-induced cell death by modulation of Notch signaling pathway. CellBio 3, 72-86. (10.4236/cellbio.2014.32008)</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/cellbio.2014.32008</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Botchway BOA, Zhang Y, Liu X. 2019. Resveratrol can inhibit Notch signaling pathway to improve spinal cord injury. Ann. Anat. 223, 100-107. (10.1016/j.aanat.2019.01.015)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aanat.2019.01.015</ArticleId><ArticleId IdType="pubmed">30797976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yin WK, Shi XD, Li Y. 2011. Curcumin activates Wnt/&#x3b2;-catenin signaling pathway through inhibiting the activity of GSK-3&#x3b2; in APPswe transfected SY5Y cells. Eur. J. Pharm. Sci. 42, 540-546. (10.1016/j.ejps.2011.02.009)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2011.02.009</ArticleId><ArticleId IdType="pubmed">21352912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Sun C, Jin Y, Gao K, Shi X, Qiu W, Ma C, Zhang L. 2017. Dickkopf 3 (Dkk3) improves amyloid-&#x3b2; pathology, cognitive dysfunction, and cerebral glucose metabolism in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 60, 733-746. (10.3233/JAD-161254)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161254</ArticleId><ArticleId IdType="pubmed">28922151</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, Wang L, Tang F, Zeng L, Zhou L, Song X, Jia W, Chen J, Yang Q. 2017. Resveratrol pretreatment decreases ischemic injury and improves neurological function via sonic hedgehog signaling after stroke in rats. Mol. Neurobiol. 54, 212-226. (10.1007/s12035-015-9639-7)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9639-7</ArticleId><ArticleId IdType="pubmed">26738852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Huang K, Wang R, Jiang Q, Wu Z, Liang W, Guo R, Wang L. 2018. Neuroprotective effects of cerebral ischemic preconditioning in a rat middle cerebral artery occlusion model: the role of the Notch signaling pathway. Biomed. Res. Int. 2018, 8168720. (10.1155/2018/8168720)</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8168720</ArticleId><ArticleId IdType="pmc">PMC6106850</ArticleId><ArticleId IdType="pubmed">30175143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. 2013. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke 44, 1965-1972. (10.1161/STROKEAHA.111.000831)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.000831</ArticleId><ArticleId IdType="pubmed">23696546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, et al. 2015. Neuroprotective effects of crocin against traumatic brain injury in mice: involvement of notch signaling pathway. Neurosci. Lett. 591, 53-58. (10.1016/j.neulet.2015.02.016)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.02.016</ArticleId><ArticleId IdType="pubmed">25681620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HM, Liu P, Jiang C, Jin XQ, Liu RN, Li SQ, Zhao Y. 2018. Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury. PLoS ONE 13, e0193037. (10.1371/journal.pone.0193037)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193037</ArticleId><ArticleId IdType="pmc">PMC5814062</ArticleId><ArticleId IdType="pubmed">29447233</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Hao S, Yang B, Fan Y, Qin X, Chen Y, Hu J. 2017. Wnt/&#x3b2;-catenin signaling plays an essential role in &#x3b1;7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model. Biochem. Pharmacol. 140, 115-123. (10.1016/j.bcp.2017.05.017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.05.017</ArticleId><ArticleId IdType="pubmed">28551099</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F, et al. 2008. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 105, 2052-2057. (10.1073/pnas.0708022105)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708022105</ArticleId><ArticleId IdType="pmc">PMC2538879</ArticleId><ArticleId IdType="pubmed">18250315</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Guo P, Li X, Ke J, Wang Y, Wu H. 2019. Neuroprotective effects of irisin against cerebral ischemia/reperfusion injury via Notch signaling pathway. Biomed. Pharmacother. 120, 109452. (10.1016/j.biopha.2019.109452)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109452</ArticleId><ArticleId IdType="pubmed">31561067</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, et al. 2017. Minocycline attenuates the development of diabetic neuropathy by inhibiting spinal cord Notch signaling in rat. Biomed. Pharmacother. 94, 380-385. (10.1016/j.biopha.2017.07.078)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.078</ArticleId><ArticleId IdType="pubmed">28772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Chechneva OV, Mayrhofer F, Daugherty DJ, Krishnamurty RG, Bannerman P, Pleasure DE, Deng W. 2014. A Smoothenedreceptor agonist is neuroprotective and promotes regeneration after ischemic brain injury. Cell Death Dis. 5, e1481. (10.1038/cddis.2014.446)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.446</ArticleId><ArticleId IdType="pmc">PMC4649529</ArticleId><ArticleId IdType="pubmed">25341035</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S, Wang GL, Raymond C, Deng XH, Zhu XL, Wang D, Hong LP. 2017. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3 K/AKt signaling pathway. Mol. Med. Rep. 16, 1269-1277. (10.3892/mmr.2017.6751)</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6751</ArticleId><ArticleId IdType="pmc">PMC5562000</ArticleId><ArticleId IdType="pubmed">28627590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HP, Sun YY, Chen XM, Yuan LB, Su BX, Ma R, Zhao RN, Dong HL, Xiong L. 2014. The neuroprotective effects of isoflurane preconditioning in a murine transient global cerebral ischemia-reperfusion model: the role of the Notch signaling pathway. Neuromolecular Med. 16, 191-204. (10.1007/s12017-013-8273-7)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-013-8273-7</ArticleId><ArticleId IdType="pubmed">24197755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, et al. 2012. Activation of canonical notch signaling pathway is involved in the ischemic tolerance induced by sevoflurane preconditioning in mice. Anesthesiology 117, 996-1005. (10.1097/ALN.0b013e31826cb469)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31826cb469</ArticleId><ArticleId IdType="pubmed">22929735</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J, Wei X, Qu S, Lv T, Fu Q, Yuan Y. 2017. Osthole prevents cerebral ischemia-reperfusion injury via the Notch signaling pathway. Biochem. Cell Biol. 95, 459-467. (10.1139/bcb-2016-0233)</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2016-0233</ArticleId><ArticleId IdType="pubmed">28257582</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, et al. 2013. Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease. J. Alzheimers Dis. 33, 941-959. (10.3233/JAD-2012-120397)</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-120397</ArticleId><ArticleId IdType="pubmed">23109558</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e A, Vall&#xe9;e J, Guillevin R, Lecarpentier Y. 2020. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/&#x3b2;-catenin pathway. Aging 12, 3095-3113. (10.18632/aging.102830)</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102830</ArticleId><ArticleId IdType="pmc">PMC7041777</ArticleId><ArticleId IdType="pubmed">32035419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisternas P, Zolezzi JM, Martinez M, Torres VI, Wong GW, Inestrosa NC. 2019. Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease. J. Neurochem. 149, 54-72. (10.1111/jnc.14608)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14608</ArticleId><ArticleId IdType="pmc">PMC7680578</ArticleId><ArticleId IdType="pubmed">30300917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. 2017. Salvianolic Acids for Injection (SAFI) promotes functional recovery and neurogenesis via sonic hedgehog pathway after stroke in mice. Neurochem. Int. 110, 38-48. (10.1016/j.neuint.2017.09.001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.09.001</ArticleId><ArticleId IdType="pubmed">28887094</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Cheng C, Liu Y, Liu N, Lo EH, Wang X. 2018. Neuroglobin promotes neurogenesis through Wnt signaling pathway. Cell Death Dis. 9, 945. (10.1038/s41419-018-1007-x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1007-x</ArticleId><ArticleId IdType="pmc">PMC6147998</ArticleId><ArticleId IdType="pubmed">30237546</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz R, Hackl S, Seibuchner T, Tamm ER, Ohlmann A. 2010. Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J. Neurosci. 30, 5998-6010. (10.1523/JNEUROSCI.0730-10.2010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0730-10.2010</ArticleId><ArticleId IdType="pmc">PMC6632606</ArticleId><ArticleId IdType="pubmed">20427659</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Lin C, Yuan L, Chen L, Guo P, Li P, Wang W, Zhang X. 2019. Preactivation of Notch1 in remote ischemic preconditioning reduces cerebral ischemia-reperfusion injury through crosstalk with the NF-&#x3ba;B pathway. J. Neuroinflammation 16, 181. (10.1186/s12974-019-1570-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1570-9</ArticleId><ArticleId IdType="pmc">PMC6747758</ArticleId><ArticleId IdType="pubmed">31526384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SD, Yang JL, Hwang WC, Yang DI. 2018. Emerging roles of sonic hedgehog in adult neurological diseases: neurogenesis and beyond. Int. J. Mol. Sci. 19, 2423. (10.3390/ijms19082423)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082423</ArticleId><ArticleId IdType="pmc">PMC6121355</ArticleId><ArticleId IdType="pubmed">30115884</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. 2019. Mesenchymal stem cells alleviate the early brain injury of subarachnoid hemorrhage partly by suppression of Notch1-dependent neuroinflammation: involvement of botch. J. Neuroinflammation 16, 8. (10.1186/s12974-019-1396-5)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1396-5</ArticleId><ArticleId IdType="pmc">PMC6334441</ArticleId><ArticleId IdType="pubmed">30646897</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Ma J, Fang Q, Li H, Shen H, Li X, Xue Q, Zhu J, Chen G. 2019. Botch protects neurons from ischemic insult by antagonizing Notch-mediated neuroinflammation. Exp. Neurol. 321, 113028. (10.1016/j.expneurol.2019.113028)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.113028</ArticleId><ArticleId IdType="pubmed">31377404</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>